[{"status": "Terminated", "city": "Brewerton", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "61256", "recalling_firm": "www.vitaminbestbuy.com", "address_1": "6001 McKinley Rd.", "address_2": "N/A", "postal_code": "13029", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1700-2012", "product_description": "Japan Weight Loss Blue Capsules, 9 g (300 mg), 30 count box, Green algae lipotropic (fat dissolving) agent, OTC, Distributed by Vitaminbestbuy.com, Brewerton, NY", "product_quantity": "52 boxes", "reason_for_recall": "Marketed Without an Approved ANDA/NDA: presence of sibutramine", "recall_initiation_date": "20120223", "center_classification_date": "20120926", "termination_date": "20181101", "report_date": "20121003", "code_info": "All lots.", "more_code_info": ""}, {"status": "Terminated", "city": "Bedford", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62490", "recalling_firm": "Ben Venue Laboratories Inc", "address_1": "300 Northfield Rd", "address_2": "N/A", "postal_code": "44146", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide and Puerto Rico.", "recall_number": "D-036-2013", "product_description": "Leucovorin Calcium Injection USP, single use vials, 10mg/mL; 50mL, Rx only, Manufactured by: Ben Venue Labs, Inc., Bedford, OH 44146, NDC# 55390-009-01(Bedford); NDC# 55390-826-01(Novaplus)", "product_quantity": "226,010 vials", "reason_for_recall": "Presence of Particulate Matter: visible crystalline particulates and the discovery of crystalline particulate in a retain sample.", "recall_initiation_date": "20120705", "center_classification_date": "20121101", "termination_date": "20130830", "report_date": "20121107", "code_info": "Lot #, 2017619 (Bedford), Mfr Item # 0967-57-2017619, NDC, 55390-009-01, Exp. Date 11/2012; Lot# 2017620, Exp. Date 1/2013, NDC #55390-009-01; Lot #, 2017621 (Bedford), Mfr Item # 0967-57-2017621, NDC, 55390-009-01, Exp Date 01/2013; Lot #2038374, exp. 2/2013, NDC #55390-009-01; Lot #2038374A, exp. 2/2013, NDC #55390-826-01 Note: 2038374A (packaged using Novaplus labeling) is a sublot of 2038374 (packaged using Bedford labeling); Lot #, 2038375 (Bedford), Mfr Item # 0967-57-2038375, NDC, 55390-009-01, Exp Date 03/2013; Lot #, 2065418 (Bedford), Mfr Item # 0967-57-2065418, NDC, 55390-009-01, Exp Date 06/2013; Lot #, 2067176 (Bedford), Mfr Item # 0967-57-2067176, NDC, 55390-009-01, Exp Date, 06/2013; Lot #, 2067177 (Bedford), Mfr Item # 0967-57-2067177, NDC, 55390-009-01, Exp Date 06/2013 & Lot #, 2067178A (Novaplus), Mfr Item # 0967-57-2067178A, NDC, 55390-826-01, Exp Date, 06/2013.", "more_code_info": ""}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63630", "recalling_firm": "Boehringer Ingelheim Roxane Inc", "address_1": "1809 Wilson Rd", "address_2": "N/A", "postal_code": "43228-9579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-067-2013", "product_description": "Pradaxa (dabigatran etexilate), 75 mg Capsules, 60 count bottles, Rx only, Distributed by Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT --- NDC 0597-0149-54", "product_quantity": "8,381 bottles", "reason_for_recall": "Defective container; damaged bottles could allow moisture to get into the bottle and thus may impair the quality of the product", "recall_initiation_date": "20121105", "center_classification_date": "20121126", "termination_date": "20130918", "report_date": "20121205", "code_info": "Lot 201900  Expiration Date: JAN 2015"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076477"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Sun Pharmaceutical Industries Inc."], "product_ndc": ["63304-827", "63304-828", "63304-829", "63304-830"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["259255", "617310", "617311", "617312"], "spl_id": ["24508d3d-eec0-4c5c-bfaa-d6e01a03fe80"], "spl_set_id": ["595ab888-6b55-4642-a32f-e8521821ed81"], "package_ndc": ["63304-827-90", "63304-827-05", "63304-828-90", "63304-828-05", "63304-829-90", "63304-829-05", "63304-830-90", "63304-830-05"], "is_original_packager": [true], "unii": ["48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "63759", "recalling_firm": "Ranbaxy Inc.", "address_1": "600 College Rd E Ste 2100", "address_2": "N/A", "postal_code": "08540-6636", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and PR", "recall_number": "D-070-2013", "product_description": "Atorvastatin Calcium Tablets, 10 mg, 90 tablets per bottle, Rx only, Manufactured for: Ranbaxy Pharmaceuticals Inc., Jacksonville, FL 32257, USA, by: Ranbaxy Laboratories Ltd., New Delhi - 110019, India, NDC #: 63304-827-90", "product_quantity": "120,201 Bottles", "reason_for_recall": "Presence of Particulate Matter: Certain batches of Atorvastatin tablets 10 mg, 20 mg and 40 mg may contain small glass particulates.", "recall_initiation_date": "20121109", "center_classification_date": "20121129", "termination_date": "20140428", "report_date": "20121205", "code_info": "Lot #s: 2436144, 2436582, 2441567, 2441568, Exp 08/31/2014."}, {"status": "Terminated", "city": "Corona", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "63246", "recalling_firm": "Watson Laboratories Inc", "address_1": "311 Bonnie Cir", "address_2": "N/A", "postal_code": "92880-2882", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-058-2013", "product_description": "Hydrocodone Bitartrate and Acetaminophen Tablets USP, 10 mg/500 mg, 500-count Tablets per bottle, Rx only, Manufactured By: Watson Laboratories, Inc., Corona, CA  92880 USA, NDC 00591-0540-05.", "product_quantity": "4,874 bottles", "reason_for_recall": "Superpotent (Multiple Ingredient) Drug: There is the potential for oversized and superpotent tablets.", "recall_initiation_date": "20120921", "center_classification_date": "20121116", "termination_date": "20140324", "report_date": "20121128", "code_info": "Lot #: 519406A, 521759A, Exp 04/14"}, {"status": "Terminated", "city": "Mehbubnagar", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62113", "recalling_firm": "Aurobindo Pharma LTD", "address_1": "Unit VII, Formulation Plant", "address_2": "Survey 411, 425, 434-435, 458, Plot S1", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "FAX", "distribution_pattern": "Nationwide", "recall_number": "D-041-2013", "product_description": "Northstar Zolpidem Tartrate Tablets USP 10 mg.  Manufactured for Northstar RX, LLC Memphis, TN 38141.  Manufactured by Aurobindo Pharma Limited, Unit VII, Mahaboob Dagar, 509302, India", "product_quantity": "23,616 bottles", "reason_for_recall": "Adulterated Presence of Foreign Tablets: This product is being recalled becaiuse 30 valacyclovir hydrochloride tablets USP 500 mg were discovered in a bottle labeled Zolpidem Tartrate tables USP 10 mg", "recall_initiation_date": "20120309", "center_classification_date": "20121106", "termination_date": "20131121", "report_date": "20121114", "code_info": "Batch Number ZPSB11054-A Exp. 05/13"}, {"status": "Terminated", "city": "Hawthorne", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090368"], "brand_name": ["FLUOROURACIL"], "generic_name": ["FLUOROURACIL"], "manufacturer_name": ["Taro Pharmaceuticals U.S.A., Inc."], "product_ndc": ["51672-4118"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["FLUOROURACIL"], "rxcui": ["105583"], "spl_id": ["170232f3-4992-1e1a-e063-6394a90a38e9"], "spl_set_id": ["acca0036-f19c-459b-9dfc-9592f1cd588d"], "package_ndc": ["51672-4118-5", "51672-4118-2", "51672-4118-6"], "is_original_packager": [true], "nui": ["N0000000233", "N0000175595"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "unii": ["U3P01618RT"]}, "product_type": "Drugs", "event_id": "63685", "recalling_firm": "Taro Pharmaceuticals U.S.A., Inc.", "address_1": "3 Skyline Dr", "address_2": "N/A", "postal_code": "10532-2174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-086-2013", "product_description": "Fluorouracil Topical Cream USP, 5%, 40 g Tube, Rx only, Mfd. by: Taro Pharmaceutical Industries, Ltd. Haifa Bay, Israel 26110, Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4118-6.", "product_quantity": "39,982 Tubes", "reason_for_recall": "Product Lacks Stability: Out-of-specification (OOS) results were observed for assay and description in retain samples.", "recall_initiation_date": "20121121", "center_classification_date": "20121204", "termination_date": "20170411", "report_date": "20121212", "code_info": "Lot #s: 118903, Exp. March 2013; 119477, 119483, 119743, Exp. May 2013; 119748, June 2013; 110440, Exp. September 2013; 110599, 110602, 110606, 110607, 110949, 110951, 110953, 110954, 110956, 110958, Exp. October 2013; 110962, 110963, 110965, 111659, 111844, Exp. November 2013; 111845, 111846, Exp. December 2013; 112227, 112228, Exp. January 2014."}, {"status": "Terminated", "city": "Minneapolis", "state": "MN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63354", "recalling_firm": "Paddock Laboratories, LLC", "address_1": "3940 Quebec Ave N", "address_2": "N/A", "postal_code": "55427-1244", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-007-2013", "product_description": "Moexipril HCl Tablets 7.5mg, 100 tabs, Rx Only, Paddock Laboratories, Inc., Minneapolis, MN 55427, NDC 0574-0110-01 ,", "product_quantity": "2267 bottles", "reason_for_recall": "Paddock Laboratories, LLC are recalling one lot   (2012028142) of Moexipril HCl Tablets 7.5mg (expiration 1/2014) because of a  non-conformity dissolution failure result found during routine stability testing at the 6 month test interval.", "recall_initiation_date": "20121003", "center_classification_date": "20121009", "termination_date": "20131112", "report_date": "20121017", "code_info": "2012028142 exp. 1/2014"}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63384", "recalling_firm": "Raritan Pharmaceuticals, Inc.", "address_1": "8 Joanna Ct", "address_2": "N/A", "postal_code": "08816-2108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-030-2013", "product_description": "Premier Value Fiber Capsules, Fiber Capsules, 100% Natural Psyllium Fiber, Relieves Constipation, Restores Regularity, 160 Capsules per bottle, Distributed by: Chain Drug Consortium, LLC, Boca Raton, FL 33431, UPC0-40986-01703-2", "product_quantity": "1,440 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.", "recall_initiation_date": "20120904", "center_classification_date": "20121025", "termination_date": "20141007", "report_date": "20121031", "code_info": "Lot 16470, Exp 08/15"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "63488", "recalling_firm": "Valeant Pharmaceuticals", "address_1": "700 Rte 206 North", "address_2": "N/A", "postal_code": "08807", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-046-2013", "product_description": "AcneFree Acne Astringent Toner Pads (salicylic acid 2% w/v); 60-count pads per jar, Dist. by: University Medical Pharmaceuticals Corp., Irvine, CA  92618, UPC 7 88521 13551 6.", "product_quantity": "71,369 jars", "reason_for_recall": "Subpotent (Single Ingredient) Drug: This product was found to be subpotent for the salicyclic acid active ingredient.", "recall_initiation_date": "20121015", "center_classification_date": "20121106", "termination_date": "20130325", "report_date": "20121114", "code_info": "All lots with expiration dates between 10/10/12 through 10/10/14 of UPC 7 88521 13551 6"}, {"status": "Terminated", "city": "Round Lake", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63189", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "Route 120 And Wilson Rd", "address_2": "N/A", "postal_code": "60073-9799", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1687-2012", "product_description": "10% Dextrose Injection USP, packaged in a 500 mL AVIVA Container, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA; product code 6E0163, NDC 0338-6347-03", "product_quantity": "2,976 containers", "reason_for_recall": "Chemical Contamination: The IV solutions were packaged in AVIVA containers which may contain trace levels of cumene hydroperoxide (CHP).", "recall_initiation_date": "20120921", "center_classification_date": "20120925", "termination_date": "20150504", "report_date": "20121003", "code_info": "Lot #: C832840, Exp 02/13", "more_code_info": ""}, {"status": "Terminated", "city": "Brewerton", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "61256", "recalling_firm": "www.vitaminbestbuy.com", "address_1": "6001 McKinley Rd.", "address_2": "N/A", "postal_code": "13029", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1699-2012", "product_description": "Man King Capsules, 2800 mg, boxes of 5 packets, OTC, Developed by:  American Wanbao Pharmaceutical International Group and Hainan Wanbao Biological Engineering Co., Ltd., 27 Heping Road, Haikou, Henan Province, UPC 9 009900 0032328", "product_quantity": "69 boxes", "reason_for_recall": "Marketed Without an Approved ANDA/NDA: presence of sildenafil.", "recall_initiation_date": "20120223", "center_classification_date": "20120926", "termination_date": "20181101", "report_date": "20121003", "code_info": "All lots.", "more_code_info": ""}, {"status": "Terminated", "city": "South San Francisco", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63243", "recalling_firm": "Genentech Inc", "address_1": "1 DNA Way", "address_2": "N/A", "postal_code": "94080-4918", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-087-2013", "product_description": "Nutropin AQ NuSpin 20 (somatropin (rDNA origin) injection} 20 mg/ 2mL Genentech, South San Francisco, CA 94080, NDC#50242-0076-01", "product_quantity": "10,306 syringes", "reason_for_recall": "Miscalibrated and/or Defective Delivery System: Genentech has received complaints  for Nutropin AQ NuSpin 10 & 20  reporting that the dose knob spun slowly and the injection took longer than usual (slow dose delivery).", "recall_initiation_date": "20120920", "center_classification_date": "20121204", "termination_date": "20131224", "report_date": "20121212", "code_info": "Lot# 936674 Exp. 09/30/13"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "63488", "recalling_firm": "Valeant Pharmaceuticals", "address_1": "700 Rte 206 North", "address_2": "N/A", "postal_code": "08807", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-048-2013", "product_description": "AcneFree Severe Maximum Strength Acne Pore Cleanser (benzoyl peroxide 5% w/v), 3 oz (85 g) canister, Dist. by: University Medical Pharmaceuticals Corp., Irvine, CA  92618, UPC 7 88521 13350 9.", "product_quantity": "10,434 canisters", "reason_for_recall": "Subpotent (Single Ingredient) Drug: This product was found to be subpotent for the benzoyl peroxide active ingredient.  Additionally, this product is mislabeled because the label either omits or erroneously added inactive ingredients to the label.", "recall_initiation_date": "20121015", "center_classification_date": "20121106", "termination_date": "20130325", "report_date": "20121114", "code_info": "All lots with expiration dates between 10/10/12 through 10/10/14 of UPC 7 88521 13550 9"}, {"country": "United States", "city": "Gainesville", "address_1": "2481 Hilton Dr", "reason_for_recall": "Labeling: Label Mix-up: The affected units were labeled incorrectly describing the product as \"ointment\" instead of \"solution.\"", "address_2": "", "product_quantity": "22 units", "code_info": "Lot 06JN1265 Exp 3/14 and 06JN1266 Exp 4/14", "center_classification_date": "20121109", "distribution_pattern": "FL, PA, and VA.", "state": "GA", "product_description": "Tobramycin Ophthalmic Oint., 0.3%, 5ml bottle, (Generic for: Tobrex), Rx only, Sterile, Mfg By Akorn, Inc., Lake Forest, IL 60045, NDC 16590-224-05,", "report_date": "20121121", "classification": "Class III", "openfda": {}, "recalling_firm": "Stat Rx USA", "recall_number": "D-050-2013", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "62940", "termination_date": "20130131", "more_code_info": "", "recall_initiation_date": "20120618", "postal_code": "30501-6213", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Tulsa", "address_1": "12515 E 55th St Ste 100", "reason_for_recall": "Presence of Particulate Matter: glass delamination", "address_2": "", "product_quantity": "20 vials", "code_info": "Lot #: 44TK, Exp 09/10; 4NQE, Exp 05/11; 4WKN, Exp 11/11; 5KZT, 5RCM, Exp 09/12; 5RZN, Exp 10/12; 5Y8Y, 60E2, Exp 12/12", "center_classification_date": "20121214", "distribution_pattern": "PA, CA", "state": "OK", "product_description": "Procrit (epoetin alfa) injection, 20000 units/mL, 4 mL vial; Mfg By: Amgen Inc., Thousand Oaks, CA  91320; Dist. By: Physicians Total Care, Tulsa, OK  74146; NDC 54868-5673-1.", "report_date": "20121226", "classification": "Class II", "openfda": {}, "recalling_firm": "Physicians Total Care, Inc.", "recall_number": "D-093-2013", "initial_firm_notification": "FAX", "product_type": "Drugs", "event_id": "63841", "termination_date": "20130507", "more_code_info": "", "recall_initiation_date": "20101004", "postal_code": "74146-6234", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "63488", "recalling_firm": "Valeant Pharmaceuticals", "address_1": "700 Rte 206 North", "address_2": "N/A", "postal_code": "08807", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-045-2013", "product_description": "AcneFree Original Strength Terminator (benzoyl peroxide 5% w/v), 1 oz. (28 g) tube, Dist. by: University Medical Pharmaceuticals Corp., Irvine, CA  92618, AFCS-0402, UPC 7 88521 12030 7.", "product_quantity": "619,029 tubes", "reason_for_recall": "Subpotent (Single Ingredient) Drug: This product was found to be subpotent for the benzoyl peroxide active ingredient.  Additionally, this product is mislabeled because the label either omits or erroneously added inactive ingredients to the label.", "recall_initiation_date": "20121015", "center_classification_date": "20121106", "termination_date": "20130325", "report_date": "20121114", "code_info": "All lots with expiration dates between 10/10/12 through 10/10/14 of UPC 7 88521 12030 7"}, {"status": "Terminated", "city": "New Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62898", "recalling_firm": "Bristol-myers Squibb Company", "address_1": "1 Squibb Dr", "address_2": "N/A", "postal_code": "08901", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-019-2013", "product_description": "Kombiglyze XR (saxagliptin and metformin HCl extended-release) tablets, Physician Sample-Not For Sale, 7 Tablets per Carton, 5 mg/500 mg, Rx only, Manufactured By: Bristol-Myers Squibb Company, Princeton NJ 08543, USA, Marketed By: Bristol-Myers Squibb Company, Princeton NJ 08543, USA and AstraZeneca Pharmaceuticals LP, Wilmington DE 19850.", "product_quantity": "N/A", "reason_for_recall": "Labeling; Correct labeled product miscart/mispack: Some Physician sample cartons were incorrectly labeled as Kombiglyze XR 2.5mg/1000mg on the external package carton, whereas the contents were Kombiglyze XR 5 mg/500 mg blister packaged tablets.  The individual blister units are labeled correctly.", "recall_initiation_date": "20120605", "center_classification_date": "20121024", "termination_date": "20130710", "report_date": "20121031", "code_info": "Lot # 1J6024PA, 1J6025PA Exp. 09/13; 1K6049PA Exp. 10/13; 1L9015WA Exp. 11/13"}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62511", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Distribution was nationwide, including Puerto Rico.  There was no foreign, military, or government distribution.", "recall_number": "D-079-2013", "product_description": "Levothroid (levothyroxine sodium tablets, USP), 112 mcg., 100-count bottles, Rx only, NDC 0456-1330-01,   Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.", "product_quantity": "37,827/100-tablet bottles", "reason_for_recall": "cGMP Deviations; does not meet in process specification requirements", "recall_initiation_date": "20120709", "center_classification_date": "20121203", "termination_date": "20131114", "report_date": "20121212", "code_info": "Lot #1096371, exp. 5/312013; and #1092299, exp. 1/31/2013"}, {"status": "Terminated", "city": "Key Colony Beach", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "62543", "recalling_firm": "Coral Rock Man, Inc.", "address_1": "420 11th Street", "address_2": "N/A", "postal_code": "33051", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Product was distributed to three distributors/wholesalers and then distributed nationwide by internet and retail sales.", "recall_number": "D-039-2013", "product_description": "Z-ROCK All Natural Male Supplement. 1 capsule blister pack, UPC 0 00309 50792 7, Distributed by Zrock USA PO Box 668297, Pompano Beach, FL 33066", "product_quantity": "unknown", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Products tested positive for Sildenafil and analogs of Sildenafil.", "recall_initiation_date": "20120716", "center_classification_date": "20121101", "termination_date": "20151130", "report_date": "20121107", "code_info": "All Lots All codes.", "more_code_info": ""}, {"status": "Terminated", "city": "South Jordan", "state": "UT", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "35255", "recalling_firm": "Merit Medical Systems, Inc", "address_1": "1600 West Merit Pkwy", "address_2": "N/A", "postal_code": "84095-2416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Connecticut, Maryland, Ohio, and South Carolina.", "recall_number": "D-040-2013", "product_description": "Merit Convenience Kits containing Cytosol Ophthalmics Balanced Salt Solution, 18 mL Single Dose Bottle, NDC 23731-8100-8, Sterile.", "product_quantity": "2470 kits", "reason_for_recall": "Lack of Assurance of Sterility: Procedure kits contain a balanced salt solution that may be contaminated with endotoxins.", "recall_initiation_date": "20060224", "center_classification_date": "20121106", "termination_date": "20130228", "report_date": "20121114", "code_info": "All convenience kits containing Part Number 8118, all lot numbers."}, {"country": "United States", "city": "Corona", "address_1": "311 Bonnie Cir", "reason_for_recall": "Impurities/Degradation Products: Out-of-specification results were obtained for a known  impurities.", "address_2": "", "product_quantity": "63,627 cartons", "code_info": "432127A Exp. 01/13, 478076A Exp. 05/13, 515539B Exp.09/13", "center_classification_date": "20121218", "distribution_pattern": "Nationwide", "state": "CA", "product_description": "Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0.1 mg/0.025 mg, 0.125 mg/0.025 mg, 0.15 mg/0.025 mg, 28-count tablets per dispenser (NDC 52544-959-28), packaged in 3-count Tablet Dispensers per carton (NDC 52544-959-31), Rx only Manufactured by: Watson Laboratories, Inc., Corona, CA 92880; Distributed by: Watson Pharma, Inc., Corona, CA 92880.", "report_date": "20121226", "classification": "Class III", "openfda": {}, "recalling_firm": "Watson Laboratories Inc", "recall_number": "D-094-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "63906", "termination_date": "20131204", "more_code_info": "", "recall_initiation_date": "20121213", "postal_code": "92880-2882", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62511", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Distribution was nationwide, including Puerto Rico.  There was no foreign, military, or government distribution.", "recall_number": "D-083-2013", "product_description": "Levothroid (levothyroxine sodium tablets, USP), 137 mcg., 100-count bottles, Rx only, NDC 0456-1331-01,   Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.", "product_quantity": "36,978/100-tablet bottles", "reason_for_recall": "cGMP Deviations; does not meet in process specification requirements", "recall_initiation_date": "20120709", "center_classification_date": "20121203", "termination_date": "20131114", "report_date": "20121212", "code_info": "Lot #1095212 exp. 4/30/2013; and #1088877, exp. 11/30/2012"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "63488", "recalling_firm": "Valeant Pharmaceuticals", "address_1": "700 Rte 206 North", "address_2": "N/A", "postal_code": "08807", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-042-2013", "product_description": "AcneFree 24 Hour Clearing System containing 1-count 4 fl oz (118 mL) Oil-Free Purifying Cleanser (benzoyl peroxide 2.5% w/v) AFCS-0101-00, 1-count 4 fl oz (118 mL) Renewing Toner AFCS-0201-01, and 1-count 2 fl oz (59 mL) Repair Lotion (benzoyl peroxide 3.7% w/v) AFCS-0301-00 per carton, Dist. by: University Medical Pharmaceuticals Corp., Irvine, CA 92618, UPC 7 88521 12008 6.", "product_quantity": "1,097,846 cartons", "reason_for_recall": "Subpotent (Single Ingredient) Drug: This product was found to be subpotent for the benzoyl peroxide active ingredient.  Additionally, this product is mislabeled because the label either omits or erroneously added inactive ingredients to the label.", "recall_initiation_date": "20121015", "center_classification_date": "20121106", "termination_date": "20130325", "report_date": "20121114", "code_info": "All lots with expiration dates between 10/10/12 through 10/10/14 of UPC 7 88521 12008 6"}, {"country": "United States", "city": "Olathe", "address_1": "805 E Old 56 Hwy", "reason_for_recall": "CGMP Deviations: The products were manufactured with raw material which contain unknown particles believed to be water and dirt.", "address_2": "", "product_quantity": "a) 216 cases; b) 75 cases; c) 29 cases", "code_info": "Lot #: a) B26221, Exp 09/18/15; b) B94221, Exp 09/05/15; c) B94221, Exp 09/05/15", "center_classification_date": "20121115", "distribution_pattern": "Nationwide", "state": "KS", "product_description": "Lemon Hand Sanitizing Wipes [n-alkyl dimethyl benzyl ammonium chloride (0.1%) and n-alkyl dimethyl ethyl benzyl ammonium chloride (0.1%)], labeled as a) Genuine Joe Cleaning Supplies, Lemon Scent, Anti-microbial Hand Sanitizing Wipes, 120-count premoistened wipes per bucket, 6 buckets per case, Manufactured for S.P. Richards Co., 6300 Highlands Pkwy., Smyma, GA  30082, UPC 0 35255 10477 7; b) Pro Chem Lemon Aid, Hand Sanitizing Wipes, 85-count premoistened wipes per bucket, 6 buckets per case, An exclusive product of: Pro Chem, Inc., 1475 Bluegrass Lakes Parkway, Alpharetta, GA  30004; c) Scrubs, Lemon Hand Sanitizer Wipes, 120-count premoistened wipes per bucket, 6 buckets per case, Manufactured in the U.S.A. by ITW Dymon, 805 E. Old 56 Highway, Olathe, KS  66061, UPC 7 64769 92991 9.", "report_date": "20121121", "classification": "Class III", "openfda": {}, "recalling_firm": "ITW Dymon", "recall_number": "D-056-2013", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "63428", "termination_date": "20140325", "more_code_info": "", "recall_initiation_date": "20120928", "postal_code": "66061", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Tulsa", "state": "OK", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "62924", "recalling_firm": "Physicians Total Care, Inc.", "address_1": "12515 E 55th St Ste 100", "address_2": "N/A", "postal_code": "74146-6234", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "FAX", "distribution_pattern": "VA", "recall_number": "D-091-2013", "product_description": "Enjuvia (synthetic conjugated estrogens, B) tablets, 0.625 mg, 30-count tablets per bottle, Rx only, Mfg. By: Teva Pharmaceuticals USA, Sellersville PA  18960; Repacked & distributed by: Physicians Total Care, Inc., Tulsa, OK  74146; NDC 54868-6163-1.", "product_quantity": "9 bottles", "reason_for_recall": "Subpotent (Single ingredient) drug : This is a sub recall of Teva's Enjuvia due to low Out of Specification (OOS) assay results.", "recall_initiation_date": "20110408", "center_classification_date": "20121211", "termination_date": "20130222", "report_date": "20121219", "code_info": "Lot #: 62QI, Exp 01/12; 6DYQ, Exp 08/12"}, {"status": "Terminated", "city": "Mason", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63661", "recalling_firm": "Procter & Gamble Co", "address_1": "8700 Mason Montgomery Rd", "address_2": "N/A", "postal_code": "45040-9462", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-069-2013", "product_description": "Vicks NyQuil Cold & Flu, Nighttime Relief, 12 FL OZ bottle, Dist. by Proctor and Gamble, Cincinnati, OH 45040. NDC 37000-808-12", "product_quantity": "17,532 bottles", "reason_for_recall": "Labeling Illegible: Portions of the product labeling in the area of the dosing directions, the warnings & other information sections is obscured.", "recall_initiation_date": "20121108", "center_classification_date": "20121129", "termination_date": "20131223", "report_date": "20121205", "code_info": "Lot #2278171941, Exp. 09/14,  Lot #2282171981, Exp. 09/14 ."}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63384", "recalling_firm": "Raritan Pharmaceuticals, Inc.", "address_1": "8 Joanna Ct", "address_2": "N/A", "postal_code": "08816-2108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-024-2013", "product_description": "Leader Fiber Capsules, 100% Natural Psyllium Fiber Laxative, Dietary Fiber Supplement, Relieves Constipation, Restores Regularity, 100 capsules per bottle, Distributed by: Cardinal Health, Dublin, OH 43017 www.myleader.com, NDC 37205-372-78, UPC 0-96295-11222-1.", "product_quantity": "2,988 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.", "recall_initiation_date": "20120904", "center_classification_date": "20121025", "termination_date": "20141007", "report_date": "20121031", "code_info": "CIN 3510963; Lots 16273,16274, Exp 06/15"}, {"country": "United States", "city": "Skillman", "address_1": "199 Grandview Rd", "reason_for_recall": "Superpotent (Single Ingredient Drug): salicylic acid", "address_2": "", "product_quantity": "1,474,462 bottles", "code_info": "0142VA, 0132VB, 0112VC, 0122VB, 0102VA, 0102VB, 0112VB  0122VA, 0092VB, 0112VA, 0092VA, 0082VA, 0072VA, 0062VA  0062VB, 0052VA, 0052VB, 0042VA, 0032VA, 0022VA, 0012VA,  0171VA, 0171VB, 0161VB, 0151VA, 0161VA, 0141VA, 0131VA  0131VB, 0121VA, 0111VA, 0101VA, 0091VA, 0081VB, 0081VA  0071VA, 0061VA, 0051VB, 0051VA, 0041VA, 0031VA, 0021VB  0011VC, 0011VB, 0190VA, 0011VA, 0180VB, 0170VB, 0180VA  0722RT, 0732RT, 0742RT, 0752RT, 1722RD, 1732RD, 1772RD  1782RD, 1792RD, 1802RD, 1802RDA, 1812RD, 1822RD, 0092RD, 0102RD, 0112RD, 0122RD, 0132RD, 0142RD, 0162RD  0172RD, 0182RD, 0192RD, 0212RD, 0202RD, 0062RD, 1451RD  1461RD, 1461RDA, 1511RD, 1521RD, 1531RD, 1661RD, 1481RD, 1571RD, 1581RD, 1591RD, 1601RD, 1611RD, 1621RD  1681RD, 1532RD, 1522RD, 1842RD, 1512RD, 1522RD, 1562RD  1582RD, 1572RD, 1722RD, 1732RD, 1742RD, 1772RD, 1782RD  1792RD, 1802RD, 1812RD, 1812RDA, 1822RD, 1842RD, 1852RD, 1872RD", "center_classification_date": "20121220", "distribution_pattern": "Nationwide", "state": "NJ", "product_description": "Clean & Clear advantage, 3-in-1 foaming wash  8 FL. OZ. (240 mL) bottle, OTC, Distributed in the US by: Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies Inc. Skillman, NJ 08558-9418 NDC 58232-0326-8", "report_date": "20121226", "classification": "Class III", "openfda": {}, "recalling_firm": "Johnson & Johnson", "recall_number": "D-098-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "63787", "termination_date": "20140429", "more_code_info": "", "recall_initiation_date": "20121204", "postal_code": "08558-1311", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62511", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Distribution was nationwide, including Puerto Rico.  There was no foreign, military, or government distribution.", "recall_number": "D-082-2013", "product_description": "Thyro-Tab 0.137 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.", "product_quantity": "3,774,541 tablets", "reason_for_recall": "cGMP Deviations; does not meet in process specification requirements", "recall_initiation_date": "20120709", "center_classification_date": "20121203", "termination_date": "20131114", "report_date": "20121212", "code_info": "Lot #HA27911 and #HA12511"}, {"status": "Ongoing", "city": "Huntsville", "state": "AL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "63138", "recalling_firm": "Vintage Pharmaceuticals LLC DBA Qualitest Pharmaceuticals", "address_1": "120 Vintage Dr NE", "address_2": "N/A", "postal_code": "35811-8216", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide.", "recall_number": "D-057-2013", "product_description": "HYDROCODONE BITARTRATE and ACETAMINOPHEN TABLETS, USP, 10 mg/500 mg, 100-count bottle, Rx only, Mfg. for:  QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811, NDC 0603-3888-21", "product_quantity": "14,445 bottles", "reason_for_recall": "Superpotent (Multiple Ingredient) Drug: Confirmed customer complaints of oversized tablets resulting in superpotent assays of both the hydrocodone and acetaminophen components.", "recall_initiation_date": "20120910", "center_classification_date": "20121116", "report_date": "20121128", "code_info": "Lot number: C1440512A, Exp 12/13"}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62511", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Distribution was nationwide, including Puerto Rico.  There was no foreign, military, or government distribution.", "recall_number": "D-081-2013", "product_description": "Levothroid (levothyroxine sodium tablets, USP),125 mcg., 100-count bottles, Rx only, NDC 0456-1324-01,   Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.", "product_quantity": "19,162/100-tablet bottles", "reason_for_recall": "cGMP Deviations; does not meet in process specification requirements", "recall_initiation_date": "20120709", "center_classification_date": "20121203", "termination_date": "20131114", "report_date": "20121212", "code_info": "Lot #1095210, exp. 4/30/2013"}, {"status": "Terminated", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078314"], "brand_name": ["NAPROXEN SODIUM"], "generic_name": ["NAPROXEN SODIUM"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-178", "68462-188", "68462-189", "68462-190", "68462-179"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NAPROXEN SODIUM"], "rxcui": ["198012", "198013", "198014", "849398", "849431"], "spl_id": ["b7cce793-fe49-4fe0-8848-fc89f7ea3832"], "spl_set_id": ["6c5bb008-e66f-4ef0-bf84-aca7eb5983e9"], "package_ndc": ["68462-188-01", "68462-188-05", "68462-189-01", "68462-189-05", "68462-190-30", "68462-190-50", "68462-190-01", "68462-190-05", "68462-178-01", "68462-178-05", "68462-179-01", "68462-179-05"], "is_original_packager": [true], "upc": ["0368462190012", "0368462179017", "0368462178010", "0368462189016", "0368462188019"], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["9TN87S3A3C", "57Y76R9ATQ"]}, "product_type": "Drugs", "event_id": "63264", "recalling_firm": "Glenmark Generics Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1701-2012", "product_description": "NAPROXEN TABLETS USP, 500 mg, 100-count Tablets per bottle, Rx only, Manufactured by: Glenmark Generics Ltd., Colvale-Bardez, Goa 403513, India; Manufactured for: Glenmark Generics Inc., USA, Mahwah, NJ 07430; NDC 68462-190-01.", "product_quantity": "unknown", "reason_for_recall": "Labeling: Label Mix-Up: Bottles labeled as Naproxen Tablets USP, 500 mg, 100-count may contain 90-count Pravastatin Sodium Tablets, 40 mg.", "recall_initiation_date": "20120706", "center_classification_date": "20120927", "termination_date": "20150813", "report_date": "20121003", "code_info": "Lot #: 02112930, 02112934, 02112941, Exp 09/14; 2112985, 02112986, 02113334, Exp 10/14; 02113360, 02113372, 02113420, 02113606, 02113663, 02113664, Exp 11/14.", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076477"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Sun Pharmaceutical Industries Inc."], "product_ndc": ["63304-827", "63304-828", "63304-829", "63304-830"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["259255", "617310", "617311", "617312"], "spl_id": ["24508d3d-eec0-4c5c-bfaa-d6e01a03fe80"], "spl_set_id": ["595ab888-6b55-4642-a32f-e8521821ed81"], "package_ndc": ["63304-827-90", "63304-827-05", "63304-828-90", "63304-828-05", "63304-829-90", "63304-829-05", "63304-830-90", "63304-830-05"], "is_original_packager": [true], "unii": ["48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "63759", "recalling_firm": "Ranbaxy Inc.", "address_1": "600 College Rd E Ste 2100", "address_2": "N/A", "postal_code": "08540-6636", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and PR", "recall_number": "D-071-2013", "product_description": "Atorvastatin Calcium Tablets, 20 mg, 90 tablets per bottle, Rx only, Manufactured for: Ranbaxy Pharmaceuticals Inc., Jacksonville, FL 32257, USA, by: Ranbaxy Laboratories Ltd., New Delhi - 110019, India, NDC #: 63304-828-90", "product_quantity": "203,198 Bottles", "reason_for_recall": "Presence of Particulate Matter: Certain batches of Atorvastatin tablets 10 mg, 20 mg and 40 mg may contain small glass particulates.", "recall_initiation_date": "20121109", "center_classification_date": "20121129", "termination_date": "20140428", "report_date": "20121205", "code_info": "Lot #s: 2436731, 2437381, 2437940, 2437942, 2437945, 2437947, 2437952, 2437953, 2437960, 2440676, 2440677, 2440680, 2440681, Exp 08/31/2014."}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63384", "recalling_firm": "Raritan Pharmaceuticals, Inc.", "address_1": "8 Joanna Ct", "address_2": "N/A", "postal_code": "08816-2108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-026-2013", "product_description": "Wal-Mucil 100% Natural Fiber, 100% Natural Psyllium Seed Husk, Fiber Laxative/Supplement, a)160 capsules per bottle (item #503663), and b) 320 capsules per bottle (Item #586143), Distributed by: Walgreen Co., 200 Wilmot Road, Deerfield, IL 60015-4616, www.walgreens.com, a) UPC 3-11917-08151-9, b) UPC 3-11917-07658-4", "product_quantity": "56,808 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.", "recall_initiation_date": "20120904", "center_classification_date": "20121025", "termination_date": "20141007", "report_date": "20121031", "code_info": "Lots a) 15952, 16270,16425, Exp 06/15; b)16459, 16466, 16467, Exp 07/15"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "63488", "recalling_firm": "Valeant Pharmaceuticals", "address_1": "700 Rte 206 North", "address_2": "N/A", "postal_code": "08807", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-044-2013", "product_description": "AcneFree Oil-Free Acne Cleanser (benzoyl peroxide 2.5% w/v), 8 fl. oz. (237 mL) bottle, Dist. by: University Medical Pharmaceuticals Corp., Irvine, CA  92618, AFCS-0101-00, UPC 7 88521 12020 8.", "product_quantity": "145,650 bottles", "reason_for_recall": "Subpotent (Single Ingredient) Drug: This product was found to be subpotent for the benzoyl peroxide active ingredient.  Additionally, this product is mislabeled because the label either omits or erroneously added inactive ingredients to the label.", "recall_initiation_date": "20121015", "center_classification_date": "20121106", "termination_date": "20130325", "report_date": "20121114", "code_info": "All lots with expiration dates between 10/10/12 through 10/10/14 of UPC 7 88521 12020 8"}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62511", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Distribution was nationwide, including Puerto Rico.  There was no foreign, military, or government distribution.", "recall_number": "D-077-2013", "product_description": "Levothroid (levothyroxine sodium tablets, USP), 88 mcg., 100-count bottles, Rx only, NDC 0456-1329-01,  Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.", "product_quantity": "31,252/100-tablet bottles", "reason_for_recall": "cGMP Deviations; does not meet in process specification requirements", "recall_initiation_date": "20120709", "center_classification_date": "20121203", "termination_date": "20131114", "report_date": "20121212", "code_info": "Lot #1096369, exp. 11/30/2012; and #1092046, exp. 7/31/2012"}, {"status": "Terminated", "city": "Santa Ana", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63095", "recalling_firm": "Dispensing Solutions, Inc", "address_1": "3000 W Warner Ave", "address_2": "N/A", "postal_code": "92704-5311", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US:  IN & WI", "recall_number": "D-1691-2012", "product_description": "Atrovent HFA Inhalation Aerosol, (ipratropium bromide) 12.9 grams, 200 metered actuations, Rx only, Packaged Exclusively by: Dispensing Solutions, Inc., Santa Ana, CA --- NDC 68258-8952-01, DSI product #8A0947", "product_quantity": "18 Inhalers", "reason_for_recall": "Label Mix up; side panel of sticker label applied by Dispensing Solutions Inc. incorrectly indicates product name as Ventolin HFA 90 mcg instead of correctly as Atrovent HFA 12.9 grams Inhalation Aerosol", "recall_initiation_date": "20120828", "center_classification_date": "20120925", "termination_date": "20121101", "report_date": "20121003", "code_info": "Lot # F23989, F22311", "more_code_info": ""}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62511", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Distribution was nationwide, including Puerto Rico.  There was no foreign, military, or government distribution.", "recall_number": "D-074-2013", "product_description": "Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.", "product_quantity": "1,923,887 tablets", "reason_for_recall": "cGMP Deviations; does not meet in process specification requirements", "recall_initiation_date": "20120709", "center_classification_date": "20121203", "termination_date": "20131114", "report_date": "20121212", "code_info": "Lot #HB01212"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62461", "recalling_firm": "Church & Dwight Inc", "address_1": "469 N Harrison St", "address_2": "N/A", "postal_code": "08540-3510", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-061-2013", "product_description": "Orajel Kids My Way! Anticavity Fluoride (sodium fluoride) toothpaste, 0.24%, 3 oz (85 g) pump, Church & Dwight Col, Inc., Princeton, NJ  08543; UPC 3 10310 32370 7.", "product_quantity": "42,768 pumps", "reason_for_recall": "CGMP Deviations: Product was made with an incorrect ingredient, Laureth-9 was mistakenly substituted for PEG.", "recall_initiation_date": "20120906", "center_classification_date": "20121121", "termination_date": "20130611", "report_date": "20121128", "code_info": "Lot #: BI1041, Exp 02/13"}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63384", "recalling_firm": "Raritan Pharmaceuticals, Inc.", "address_1": "8 Joanna Ct", "address_2": "N/A", "postal_code": "08816-2108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-023-2013", "product_description": "Equate Fiber Therapy, 100% Natural Psyllium Husk Fiber, Fiber Laxative/Fiber Supplement, 160 capsules per bottle, Distributed by: Wal-Mart Stores, Inc., Bentonville, AR 72716, NDC 68163-119-60, UPC 6-81131-77922-7.", "product_quantity": "183,141 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.", "recall_initiation_date": "20120904", "center_classification_date": "20121025", "termination_date": "20141007", "report_date": "20121031", "code_info": "Item Number: 4091097; Lots 15952, 16271, 16274, 16425, Exp 06/15;  16434, 16435, 16436, 16459, 16461, 16462,16465, Exp 07/15"}, {"status": "Terminated", "city": "Abbott Park", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021402"], "brand_name": ["SYNTHROID"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["AbbVie Inc."], "product_ndc": ["0074-3727", "0074-4341", "0074-4552", "0074-5182", "0074-6594", "0074-6624", "0074-9296", "0074-7068", "0074-7069", "0074-7070", "0074-7148", "0074-7149"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966158", "966171", "966185", "966191", "966201", "966205", "966218", "966220", "966221", "966222", "966224", "966225", "966247", "966248", "966249", "966250", "966251", "966253", "966270", "966271", "966282"], "spl_id": ["b85ab7fa-ba96-43cd-b736-44b3924e644c"], "spl_set_id": ["1e11ad30-1041-4520-10b0-8f9d30d30fcc"], "package_ndc": ["0074-4341-13", "0074-4341-90", "0074-4341-19", "0074-4341-72", "0074-4552-13", "0074-4552-90", "0074-4552-19", "0074-4552-11", "0074-4552-71", "0074-4552-72", "0074-5182-13", "0074-5182-90", "0074-5182-71", "0074-5182-19", "0074-5182-11", "0074-5182-72", "0074-6594-13", "0074-6594-90", "0074-6594-71", "0074-6594-19", "0074-6594-72", "0074-6624-13", "0074-6624-90", "0074-6624-19", "0074-6624-11", "0074-6624-71", "0074-6624-72", "0074-9296-13", "0074-9296-90", "0074-9296-19", "0074-9296-71", "0074-9296-72", "0074-7068-13", "0074-7068-90", "0074-7068-71", "0074-7068-19", "0074-7068-11", "0074-7068-72", "0074-3727-13", "0074-3727-90", "0074-3727-71", "0074-3727-19", "0074-3727-72", "0074-7069-90", "0074-7069-71", "0074-7069-19", "0074-7069-11", "0074-7069-72", "0074-7070-13", "0074-7070-90", "0074-7070-71", "0074-7070-19", "0074-7070-72", "0074-7148-90", "0074-7148-19", "0074-7148-71", "0074-7148-11", "0074-7148-72", "0074-7149-90", "0074-7149-19"], "is_original_packager": [true], "upc": ["0300747070190", "0300747069903", "0300749296192", "0300743727906", "0300747148905", "0300746624905", "0300747149902", "0300747068197", "0300744341194", "0300745182192"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "62674", "recalling_firm": "Abbott Laboratories", "address_1": "100 Abbott Park Rd", "address_2": "N/A", "postal_code": "60064-3502", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1696-2012", "product_description": "Synthroid (levothyroxine sodium) Tablets USP, 112 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, North Chicago, IL 60064, NDC: 0074-9296-90", "product_quantity": "40,464 Bottles", "reason_for_recall": "Defective Container: A number of Synthroid bottles have a localized thin wall defect on the bottom which may potentially impact the stability of the tablets.", "recall_initiation_date": "20120719", "center_classification_date": "20120926", "termination_date": "20131101", "report_date": "20121003", "code_info": "Lot: 18355A8, Exp. 09/26/13", "more_code_info": ""}, {"status": "Terminated", "city": "Abbott Park", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021402"], "brand_name": ["SYNTHROID"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["AbbVie Inc."], "product_ndc": ["0074-3727", "0074-4341", "0074-4552", "0074-5182", "0074-6594", "0074-6624", "0074-9296", "0074-7068", "0074-7069", "0074-7070", "0074-7148", "0074-7149"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966158", "966171", "966185", "966191", "966201", "966205", "966218", "966220", "966221", "966222", "966224", "966225", "966247", "966248", "966249", "966250", "966251", "966253", "966270", "966271", "966282"], "spl_id": ["b85ab7fa-ba96-43cd-b736-44b3924e644c"], "spl_set_id": ["1e11ad30-1041-4520-10b0-8f9d30d30fcc"], "package_ndc": ["0074-4341-13", "0074-4341-90", "0074-4341-19", "0074-4341-72", "0074-4552-13", "0074-4552-90", "0074-4552-19", "0074-4552-11", "0074-4552-71", "0074-4552-72", "0074-5182-13", "0074-5182-90", "0074-5182-71", "0074-5182-19", "0074-5182-11", "0074-5182-72", "0074-6594-13", "0074-6594-90", "0074-6594-71", "0074-6594-19", "0074-6594-72", "0074-6624-13", "0074-6624-90", "0074-6624-19", "0074-6624-11", "0074-6624-71", "0074-6624-72", "0074-9296-13", "0074-9296-90", "0074-9296-19", "0074-9296-71", "0074-9296-72", "0074-7068-13", "0074-7068-90", "0074-7068-71", "0074-7068-19", "0074-7068-11", "0074-7068-72", "0074-3727-13", "0074-3727-90", "0074-3727-71", "0074-3727-19", "0074-3727-72", "0074-7069-90", "0074-7069-71", "0074-7069-19", "0074-7069-11", "0074-7069-72", "0074-7070-13", "0074-7070-90", "0074-7070-71", "0074-7070-19", "0074-7070-72", "0074-7148-90", "0074-7148-19", "0074-7148-71", "0074-7148-11", "0074-7148-72", "0074-7149-90", "0074-7149-19"], "is_original_packager": [true], "upc": ["0300747070190", "0300747069903", "0300749296192", "0300743727906", "0300747148905", "0300746624905", "0300747149902", "0300747068197", "0300744341194", "0300745182192"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "62674", "recalling_firm": "Abbott Laboratories", "address_1": "100 Abbott Park Rd", "address_2": "N/A", "postal_code": "60064-3502", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1695-2012", "product_description": "Synthroid (levothyroxine sodium) Tablets USP, 75 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, North Chicago, IL 60064, NDC: 0074-5182-90.", "product_quantity": "42,596 Bottles", "reason_for_recall": "Defective Container: A number of Synthroid bottles have a localized thin wall defect on the bottom which may potentially impact the stability of the tablets.", "recall_initiation_date": "20120719", "center_classification_date": "20120926", "termination_date": "20131101", "report_date": "20121003", "code_info": "Lot: 18353A8, Exp 08/31/2013", "more_code_info": ""}, {"status": "Terminated", "city": "Abbott Park", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021402"], "brand_name": ["SYNTHROID"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["AbbVie Inc."], "product_ndc": ["0074-3727", "0074-4341", "0074-4552", "0074-5182", "0074-6594", "0074-6624", "0074-9296", "0074-7068", "0074-7069", "0074-7070", "0074-7148", "0074-7149"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966158", "966171", "966185", "966191", "966201", "966205", "966218", "966220", "966221", "966222", "966224", "966225", "966247", "966248", "966249", "966250", "966251", "966253", "966270", "966271", "966282"], "spl_id": ["b85ab7fa-ba96-43cd-b736-44b3924e644c"], "spl_set_id": ["1e11ad30-1041-4520-10b0-8f9d30d30fcc"], "package_ndc": ["0074-4341-13", "0074-4341-90", "0074-4341-19", "0074-4341-72", "0074-4552-13", "0074-4552-90", "0074-4552-19", "0074-4552-11", "0074-4552-71", "0074-4552-72", "0074-5182-13", "0074-5182-90", "0074-5182-71", "0074-5182-19", "0074-5182-11", "0074-5182-72", "0074-6594-13", "0074-6594-90", "0074-6594-71", "0074-6594-19", "0074-6594-72", "0074-6624-13", "0074-6624-90", "0074-6624-19", "0074-6624-11", "0074-6624-71", "0074-6624-72", "0074-9296-13", "0074-9296-90", "0074-9296-19", "0074-9296-71", "0074-9296-72", "0074-7068-13", "0074-7068-90", "0074-7068-71", "0074-7068-19", "0074-7068-11", "0074-7068-72", "0074-3727-13", "0074-3727-90", "0074-3727-71", "0074-3727-19", "0074-3727-72", "0074-7069-90", "0074-7069-71", "0074-7069-19", "0074-7069-11", "0074-7069-72", "0074-7070-13", "0074-7070-90", "0074-7070-71", "0074-7070-19", "0074-7070-72", "0074-7148-90", "0074-7148-19", "0074-7148-71", "0074-7148-11", "0074-7148-72", "0074-7149-90", "0074-7149-19"], "is_original_packager": [true], "upc": ["0300747070190", "0300747069903", "0300749296192", "0300743727906", "0300747148905", "0300746624905", "0300747149902", "0300747068197", "0300744341194", "0300745182192"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "62674", "recalling_firm": "Abbott Laboratories", "address_1": "100 Abbott Park Rd", "address_2": "N/A", "postal_code": "60064-3502", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1694-2012", "product_description": "Synthroid (levothyroxine sodium) Tablets USP, 50 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, North Chicago, IL 60064, NDC: 0074-4552-90.", "product_quantity": "53,448 Bottles", "reason_for_recall": "Defective Container: A number of Synthroid bottles have a localized thin wall defect on the bottom which may potentially impact the stability of the tablets.", "recall_initiation_date": "20120719", "center_classification_date": "20120926", "termination_date": "20131101", "report_date": "20121003", "code_info": "18265A8, Exp 09/20/2013", "more_code_info": ""}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63384", "recalling_firm": "Raritan Pharmaceuticals, Inc.", "address_1": "8 Joanna Ct", "address_2": "N/A", "postal_code": "08816-2108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-028-2013", "product_description": "Berkley & Jensen Fiber Capsules, Fiber Laxative/Fiber Supplement, 100% Natural Psyllium Fiber, 400 capsules per bottle, Distributed by: BJWC, 25 Research Drive, Westborough, MA 01581, Made in USA, UPC 4-00016-27053-2.", "product_quantity": "3,552 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.", "recall_initiation_date": "20120904", "center_classification_date": "20121025", "termination_date": "20141007", "report_date": "20121031", "code_info": "Lot 16470, Exp 08/15"}, {"status": "Terminated", "city": "Corona", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63509", "recalling_firm": "Watson Laboratories Inc", "address_1": "311 Bonnie Cir", "address_2": "N/A", "postal_code": "92880-2882", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-016-2013", "product_description": "Necon 10/11 (norethindrone and ethinyl estradiol) Tablets USP, 0.5 mg/35 mcg, 1 mg/35 mcg, inert tablets, 28-count tablets per dispenser packaged in 6 Tablet Dispensers per carton, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA  92880 USA; Distributed by: Watson Pharma, Inc.; NDC 52544-554-28.", "product_quantity": "1,684 cartons", "reason_for_recall": "Cross Contamination With Other Products: The firm recalled Zovia, Lutera, Necon, and Zenchent, because certain lots could potentially be contaminated with trace amounts of Hydrochlorothiazide (HCTZ).", "recall_initiation_date": "20121019", "center_classification_date": "20121024", "termination_date": "20131121", "report_date": "20121031", "code_info": "Lot # 512642B, Exp 08/31/13"}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63384", "recalling_firm": "Raritan Pharmaceuticals, Inc.", "address_1": "8 Joanna Ct", "address_2": "N/A", "postal_code": "08816-2108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-027-2013", "product_description": "Wal-Mucil Plus Calcium Fiber Capsules,100% Natural Fiber, 100% Natural Psyllium Seed Husk, Calcium/Dietary Fiber Supplement, 240 Capsules per bottle, Distributed by: Walgreen Co., 200 Wilmot Road, Deerfield, IL 60015-4616 www.walgreens.com, NDC 0363-0128-24, UPC 3-11917-07656-0.", "product_quantity": "7,608 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.", "recall_initiation_date": "20120904", "center_classification_date": "20121025", "termination_date": "20141007", "report_date": "20121031", "code_info": "Item 586144, Lots 15085, Exp 04/15; 15086, 15087, Exp 08/15"}, {"status": "Terminated", "city": "Corona", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63509", "recalling_firm": "Watson Laboratories Inc", "address_1": "311 Bonnie Cir", "address_2": "N/A", "postal_code": "92880-2882", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-013-2013", "product_description": "Zovia (ethynodiol diacetate and ethinyl estradiol) Tablets USP, 1 mg/35 mcg, inert tablets, 28-count tablets per dispenser packaged in 6 Tablet Dispensers per carton, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA  92880 USA; Distributed by: Watson Pharma, Inc.; NDC 52544-383-28.", "product_quantity": "30,267 cartons", "reason_for_recall": "Cross Contamination With Other Products: The firm recalled Zovia, Lutera, Necon, and Zenchent, because certain lots could potentially be contaminated with trace amounts of Hydrochlorothiazide (HCTZ).", "recall_initiation_date": "20121019", "center_classification_date": "20121024", "termination_date": "20131121", "report_date": "20121031", "code_info": "Lot #: 515622AA, 515623AA, and 515623BA, Exp 09/30/13"}, {"status": "Terminated", "city": "Zebulon", "state": "NC", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA021254"], "brand_name": ["ADVAIR HFA"], "generic_name": ["FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE"], "manufacturer_name": ["GlaxoSmithKline LLC"], "product_ndc": ["0173-0715", "0173-0716", "0173-0717"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["FLUTICASONE PROPIONATE", "SALMETEROL XINAFOATE"], "rxcui": ["896231", "896235", "896236", "896237", "896239", "896243", "896244", "896245", "896267", "896271", "896272", "896273"], "spl_id": ["6fba7158-0e93-43af-b18b-89ed7d4dcc8d"], "spl_set_id": ["dfaca6f9-3277-47b2-319d-1377917cb54c"], "package_ndc": ["0173-0715-20", "0173-0715-22", "0173-0716-20", "0173-0716-22", "0173-0717-20", "0173-0717-22"], "is_original_packager": [true], "unii": ["6EW8Q962A5", "O2GMZ0LF5W"]}, "product_type": "Drugs", "event_id": "63707", "recalling_firm": "GlaxoSmithKline, LLC.", "address_1": "1011 North Arendell Ave", "address_2": "N/A", "postal_code": "27597-1217", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico.", "recall_number": "D-064-2013", "product_description": "Advair HFA (fluticasone propionate 45 mcg and salmeterol 21 mcg) Inhalation Aerosol, 12g, 120 Metered Actuations, For Oral Inhalation with Advair HFA actuator only, Rx only, GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 0173-0715-20.", "product_quantity": "310,964 Aerosol Units", "reason_for_recall": "Product Lacks Stability: These lots are being recalled due to the failure to meet the particle size distribution specification.", "recall_initiation_date": "20121024", "center_classification_date": "20121123", "termination_date": "20140911", "report_date": "20121205", "code_info": "Lot #: 1ZP2465, Exp Oct-12, 1ZP5224, Exp. Nov-12, 1ZP5455, 1ZP6916, Exp. Dec-12, 1ZP8042, 1ZP9593, Exp Jan-13, 1ZP9900, Exp. Mar-13, 1ZP1134, Exp. Apr-13, 1ZP3190, 2ZP6531, Exp. May-13, 2ZP6924, 2ZP7258, Exp. Jul-13, 2ZP1886, 2ZP9975, 2ZP0027, 2ZP9782, Exp. Sep-13, 2ZP1331, Exp. Oct-13, 2ZP2366, Exp. Nov-13."}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63384", "recalling_firm": "Raritan Pharmaceuticals, Inc.", "address_1": "8 Joanna Ct", "address_2": "N/A", "postal_code": "08816-2108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-021-2013", "product_description": "Best Choice Health Care, Psyllium Fiber Supplement, 100% natural Psyllium Fiber Laxative, 100 capsules per bottle, Proudly Distributed by: Valu Merchandisers, Co., Kansas City, KS 06106, UPC 0-70038-63439-3", "product_quantity": "2160  bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.", "recall_initiation_date": "20120904", "center_classification_date": "20121025", "termination_date": "20141007", "report_date": "20121031", "code_info": "Lot 16273, Exp 06/15"}, {"status": "Terminated", "city": "Zebulon", "state": "NC", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA021254"], "brand_name": ["ADVAIR HFA"], "generic_name": ["FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE"], "manufacturer_name": ["GlaxoSmithKline LLC"], "product_ndc": ["0173-0715", "0173-0716", "0173-0717"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["FLUTICASONE PROPIONATE", "SALMETEROL XINAFOATE"], "rxcui": ["896231", "896235", "896236", "896237", "896239", "896243", "896244", "896245", "896267", "896271", "896272", "896273"], "spl_id": ["6fba7158-0e93-43af-b18b-89ed7d4dcc8d"], "spl_set_id": ["dfaca6f9-3277-47b2-319d-1377917cb54c"], "package_ndc": ["0173-0715-20", "0173-0715-22", "0173-0716-20", "0173-0716-22", "0173-0717-20", "0173-0717-22"], "is_original_packager": [true], "unii": ["6EW8Q962A5", "O2GMZ0LF5W"]}, "product_type": "Drugs", "event_id": "63707", "recalling_firm": "GlaxoSmithKline, LLC.", "address_1": "1011 North Arendell Ave", "address_2": "N/A", "postal_code": "27597-1217", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico.", "recall_number": "D-065-2013", "product_description": "Advair HFA (fluticasone propionate/salmeterol) Inhalation Aerosol, 45mcg/21 mcg  60 Actuations INST, NDC 0173-0715-22, Rx only, GlaxoSmithKline, Research Triangle Park, NC 27709.", "product_quantity": "18,676 Aerosol Units", "reason_for_recall": "Product Lacks Stability: These lots are being recalled due to the failure to meet the particle size distribution specification.", "recall_initiation_date": "20121024", "center_classification_date": "20121123", "termination_date": "20140911", "report_date": "20121205", "code_info": "1ZP3065, Exp. Oct-12, 1ZP5453, Exp. Dec-12, 1ZP3315, Exp. May-13, 2ZP9974, Exp. Sep-13."}, {"country": "United States", "city": "Framingham", "address_1": "697 Waverly St", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "", "code_info": "All lot codes", "center_classification_date": "20121114", "distribution_pattern": "Nationwide  Japan", "state": "MA", "product_description": "All Sterile Products manufactured by NECC (New England Compounding Center), Framingham, MA.  A complete list of products can be found on their website at www.neccrx.com", "report_date": "20121121", "classification": "Class II", "openfda": {}, "recalling_firm": "New England Compounding Center", "recall_number": "D-052-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "63511", "termination_date": "20161007", "more_code_info": "", "recall_initiation_date": "20121006", "postal_code": "01702-8589", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "New Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62898", "recalling_firm": "Bristol-myers Squibb Company", "address_1": "1 Squibb Dr", "address_2": "N/A", "postal_code": "08901", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-018-2013", "product_description": "Kombiglyze XR (saxagliptin and metformin HCl extended-release) tablets, Physician Sample-Not For Sale, 6 Tablets per Carton, 2.5 mg/1000 mg, Rx only, Manufactured By: Bristol-Myers Squibb Company, Princeton NJ 08543, USA, Marketed By: Bristol-Myers Squibb Company, Princeton NJ 08543, USA and AstraZeneca Pharmaceuticals LP, Wilmington DE 19850.", "product_quantity": "117,049 Sample Cartons", "reason_for_recall": "Labeling; Correct labeled product miscart/mispack: Some Physician sample cartons were incorrectly labeled as Kombiglyze XR 2.5mg/1000mg on the external package carton, whereas the contents were Kombiglyze XR 5 mg/500 mg blister packaged tablets.  The individual blister units are labeled correctly.", "recall_initiation_date": "20120605", "center_classification_date": "20121024", "termination_date": "20130710", "report_date": "20121031", "code_info": "Lot # 1J6024PA , 1J6025PA Exp. 09/13; 1K6049PA Exp. 10/13; 1L9015WA Exp. 11/13"}, {"status": "Terminated", "city": "Caguas", "state": "PR", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090596"], "brand_name": ["TACROLIMUS"], "generic_name": ["TACROLIMUS"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-2045", "0378-2046", "0378-2047"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TACROLIMUS"], "spl_id": ["7d8a5bab-a744-4aa7-b28f-d0c2c5a53628"], "spl_set_id": ["45af3eda-caaa-4478-9372-95aa65adc9b3"], "package_ndc": ["0378-2045-01", "0378-2046-01", "0378-2047-01"], "is_original_packager": [true], "upc": ["0303782046014", "0303782045017", "0303782047011"], "unii": ["WM0HAQ4WNM"]}, "product_type": "Drugs", "event_id": "62454", "recalling_firm": "Mylan LLC.", "address_1": "Road #156, Km. 58.8, Lot 24B", "address_2": "N/A", "postal_code": "00725", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Natiowide", "recall_number": "D-066-2013", "product_description": "Mylan, Tacrolimus Capsules 0.5 mg, 100 count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 NDC 0378-2045-01", "product_quantity": "15181 bottles.", "reason_for_recall": "Failed USP Content Uniformity Requirements: OOS result reported on retained samples.", "recall_initiation_date": "20120629", "center_classification_date": "20121126", "termination_date": "20170413", "report_date": "20121205", "code_info": "Lots: 3027684 Exp. 5/13, 3027688 Exp. 6/13  2002157 Exp. 9/12"}, {"status": "Terminated", "city": "Tulsa", "state": "OK", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "62924", "recalling_firm": "Physicians Total Care, Inc.", "address_1": "12515 E 55th St Ste 100", "address_2": "N/A", "postal_code": "74146-6234", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "FAX", "distribution_pattern": "VA", "recall_number": "D-092-2013", "product_description": "Enjuvia (synthetic conjugated estrogens, B) tablets, 0.9mg, 30-count tablets per bottle, Rx only, Mfg. By: Duramed Pharmaceuticals, Pomona NY 10970; Repacked & distributed by: Physicians Total Care, Inc., Tulsa, OK  74146; NDC 54868-6165-1.", "product_quantity": "5 Bottles", "reason_for_recall": "Subpotent (Single ingredient) drug : This is a sub recall of Teva's Enjuvia due to low Out of Specification (OOS) assay results.", "recall_initiation_date": "20110408", "center_classification_date": "20121211", "termination_date": "20130222", "report_date": "20121219", "code_info": "Lot # 62QH, Exp 4/12"}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63384", "recalling_firm": "Raritan Pharmaceuticals, Inc.", "address_1": "8 Joanna Ct", "address_2": "N/A", "postal_code": "08816-2108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-022-2013", "product_description": "CVS Pharmacy Fiber Capsules for Regularity, Dietary Fiber Supplement, 100 Capsules per bottle, Distributed by: CVS Pharmacy, Inc., Woonsocket, RI 02895 www.cvs.com  UPC 0-50428-07739-9", "product_quantity": "16,848 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.", "recall_initiation_date": "20120904", "center_classification_date": "20121025", "termination_date": "20141007", "report_date": "20121031", "code_info": "Lots 16273, 16274, Exp 06/15; 16463, Exp 07/15"}, {"status": "Terminated", "city": "Norwalk", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "63017", "recalling_firm": "Samantha Lynn, Inc", "address_1": "10503 Meadow Rd", "address_2": "N/A", "postal_code": "90650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide and Canada, Australia, Germany, Brazil, Austria, United Kingdom, India, Chile, Switzerland, Thailand, Japan", "recall_number": "D-063-2013", "product_description": "Reumofan Plus Tablets, 30-count bottle per Box, (remaining label information in Spanish)", "product_quantity": "25,888 Boxes", "reason_for_recall": "Marketed without an approved NDA/ANDA: Samantha Lynn Inc. is recalling Reumofan Plus Tablets because it contains undeclared drug ingredients making it an unapproved drug.", "recall_initiation_date": "20120827", "center_classification_date": "20121123", "termination_date": "20130318", "report_date": "20121205", "code_info": "all lots within expiry through 2016"}, {"status": "Terminated", "city": "South San Francisco", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63243", "recalling_firm": "Genentech Inc", "address_1": "1 DNA Way", "address_2": "N/A", "postal_code": "94080-4918", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-088-2013", "product_description": "Nutropin AQ NuSpin 10 (somatropin (rDNA origin) injection} 10 mg/ 2mL Genentech, South San Francisco, CA 94080, NDC#50242-0074-01", "product_quantity": "12,791 syringes", "reason_for_recall": "Miscalibrated and/or Defective Delivery System: Genentech has received complaints  for Nutropin AQ NuSpin 10 & 20  reporting that the dose knob spun slowly and the injection took longer than usual (slow dose delivery).", "recall_initiation_date": "20120920", "center_classification_date": "20121204", "termination_date": "20131224", "report_date": "20121212", "code_info": "Lot # 936670 Exp. 09/30/13"}, {"status": "Terminated", "city": "Huntsville", "state": "AL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63502", "recalling_firm": "Vintage Pharmaceuticals LLC DBA Qualitest Pharmaceuticals", "address_1": "120 Vintage Dr NE", "address_2": "N/A", "postal_code": "35811-8216", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-010-2013", "product_description": "Perphenazine Tablets, USP, 8 mg, 100-count tablets per bottle, Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL  35811,  NDC 0603-5092-21.", "product_quantity": "2,755 bottles", "reason_for_recall": "Tablet Separation: Possibility of cracked or split coating on the tablets.", "recall_initiation_date": "20121011", "center_classification_date": "20121022", "termination_date": "20131209", "report_date": "20121031", "code_info": "Lot C1130511A, Exp 5/13"}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62511", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Distribution was nationwide, including Puerto Rico.  There was no foreign, military, or government distribution.", "recall_number": "D-085-2013", "product_description": "Levothroid (levothyroxine sodium tablets, USP), 300 mcg., 100-count bottles, Rx only, NDC 0456-1328-01,   Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.", "product_quantity": "1,443/100-tablet bottles", "reason_for_recall": "cGMP Deviations; does not meet in process specification requirements", "recall_initiation_date": "20120709", "center_classification_date": "20121203", "termination_date": "20131114", "report_date": "20121212", "code_info": "Lot #1097178 exp. 7/31/2013"}, {"status": "Terminated", "city": "Sarasota", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63378", "recalling_firm": "DermaCare, Inc.", "address_1": "458 Island Circle", "address_2": "N/A", "postal_code": "34242", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-034-2013", "product_description": "UP & UP brand, kid's foaming hand sanitizer, alcohol free, 99.9% effective against germs, Apple-cleani,  6.7FL oz (200mL), Distributed by Target Corp., Minneapollis, MN 55403", "product_quantity": "25,956 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Laboratory findings of high total plate count above specification.", "recall_initiation_date": "20120917", "center_classification_date": "20121101", "termination_date": "20140801", "report_date": "20121107", "code_info": "Batch 1782-01059, 2072-01059, and 2082-01195", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076477"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Sun Pharmaceutical Industries Inc."], "product_ndc": ["63304-827", "63304-828", "63304-829", "63304-830"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["259255", "617310", "617311", "617312"], "spl_id": ["24508d3d-eec0-4c5c-bfaa-d6e01a03fe80"], "spl_set_id": ["595ab888-6b55-4642-a32f-e8521821ed81"], "package_ndc": ["63304-827-90", "63304-827-05", "63304-828-90", "63304-828-05", "63304-829-90", "63304-829-05", "63304-830-90", "63304-830-05"], "is_original_packager": [true], "unii": ["48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "63623", "recalling_firm": "Ranbaxy Inc.", "address_1": "600 College Rd E Ste 2100", "address_2": "N/A", "postal_code": "08540-6636", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-060-2013", "product_description": "Atorvastatin Calcium Tablets, 10 mg, 90-count tablets per bottle, Rx only, Manufactured for: Ranbaxy Pharmaceuticals Inc., Jacksonville, FL 32257 USA; by: Ranbaxy Laboratories Ltd., New Delhi -110 019, India; NDC 63304-827-90", "product_quantity": "32,208 bottles", "reason_for_recall": "Adulterated Presence of Foreign Tablets: A product complaint was received by a pharmacist who discovered an Atorvastatin 20 mg tablet inside a sealed bottle of 90-count Atorvastatin 10 mg.", "recall_initiation_date": "20120821", "center_classification_date": "20121121", "termination_date": "20140306", "report_date": "20121128", "code_info": "Lot #: 2407258, Exp 05/14"}, {"status": "Terminated", "city": "Brewerton", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "61256", "recalling_firm": "www.vitaminbestbuy.com", "address_1": "6001 McKinley Rd.", "address_2": "N/A", "postal_code": "13029", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1698-2012", "product_description": "Hard Ten Days Capsule, 4500 mg, boxes of 6 packets, OTC, Developed by:  American Federal International Living Creature Group and Tibet Gold Source Living Creature Engineering Limited Company, Unit 18, 55 Beijing Road Central, Lhasa, Tibet", "product_quantity": "550 boxes", "reason_for_recall": "Marketed Without an Approved ANDA/NDA:  presence of sildenafil", "recall_initiation_date": "20120223", "center_classification_date": "20120926", "termination_date": "20181101", "report_date": "20121003", "code_info": "All lots.", "more_code_info": ""}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62511", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Distribution was nationwide, including Puerto Rico.  There was no foreign, military, or government distribution.", "recall_number": "D-078-2013", "product_description": "Thyro-Tab 0.112 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.", "product_quantity": "3,813,645 tablets", "reason_for_recall": "cGMP Deviations; does not meet in process specification requirements", "recall_initiation_date": "20120709", "center_classification_date": "20121203", "termination_date": "20131114", "report_date": "20121212", "code_info": "Lot #HC31411 and  #HE18711"}, {"country": "United States", "city": "South San Francisco", "address_1": "1 DNA Way", "reason_for_recall": "Short Fill: some bottles contained less than 120-count per labeled claim.", "address_2": "", "product_quantity": "1128 bottles", "code_info": "Lot #: a) M1365B01, Exp 04/15; b) M1365, Exp 04/15", "center_classification_date": "20121220", "distribution_pattern": "Nationwide", "state": "CA", "product_description": "CellCept (mycophenolate mofetil) capsules, 250 mg, packaged in a) 12 x 120-count bottles per carton, NDC 0004-0259-05; b) 120-count capsules per bottle, NDC 0004-0259-51; Made in Ireland; Distributed by: Genentech USA, Inc., South San Francisco, CA  94080.", "report_date": "20121226", "classification": "Class III", "openfda": {}, "recalling_firm": "Genentech, Inc.", "recall_number": "D-097-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "63874", "termination_date": "20141120", "more_code_info": "", "recall_initiation_date": "20120927", "postal_code": "94080-4990", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077380"], "brand_name": ["QUETIAPINE FUMARATE"], "generic_name": ["QUETIAPINE FUMARATE"], "manufacturer_name": ["Dr.Reddy's Laboratories Limited"], "product_ndc": ["55111-169", "55111-186", "55111-188", "55111-189", "55111-190", "55111-606", "55111-249"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["QUETIAPINE FUMARATE"], "rxcui": ["312743", "312744", "312745", "317174", "389201", "616483", "616487"], "spl_id": ["032c7109-eeca-170e-54d0-cfb44f135f07"], "spl_set_id": ["26d92d06-44c5-51ac-27f2-cb1376f6bb68"], "package_ndc": ["55111-169-30", "55111-169-60", "55111-169-01", "55111-169-05", "55111-169-79", "55111-169-78", "55111-186-30", "55111-186-60", "55111-186-01", "55111-186-05", "55111-186-79", "55111-186-78", "55111-188-30", "55111-188-60", "55111-188-01", "55111-188-05", "55111-188-79", "55111-188-78", "55111-189-30", "55111-189-60", "55111-189-01", "55111-189-05", "55111-189-79", "55111-189-78", "55111-190-30", "55111-190-60", "55111-190-01", "55111-190-05", "55111-190-79", "55111-190-78", "55111-606-30", "55111-606-60", "55111-606-01", "55111-606-05", "55111-606-79", "55111-606-78", "55111-249-30", "55111-249-60", "55111-249-01", "55111-249-05", "55111-249-79", "55111-249-78"], "is_original_packager": [true], "unii": ["2S3PL1B6UJ"]}, "product_type": "Drugs", "event_id": "63524", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "200 Somerset Corporate Blvd Fl 7th", "address_2": "N/A", "postal_code": "08807-2862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.  No foreign consignees.", "recall_number": "D-059-2013", "product_description": "Dr. Reddy's Quetiapine Fumarate Tablets, 25mg, Rx Only, 500 tablets.    Mfd By: Dr. Reddy's Laboratories Limited, Bachepalli - 502 325, India    NDC 55111-249-05", "product_quantity": "1512 bottles", "reason_for_recall": "Failed USP Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg.", "recall_initiation_date": "20120927", "center_classification_date": "20121120", "termination_date": "20130710", "report_date": "20121128", "code_info": "Lot C203090 Exp.03/14"}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63284", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-033-2013", "product_description": "Doxazosin Tablets, USP, 2 mg, 100 count bottles, labeled in part ***Manufactured in Australia by: ALPHAPHARM PTY LTD, 15 Garnet Street***Rx Only***  Carole Park QLD 4300, Australia*** Manufactured for Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.SA ***", "product_quantity": "24,331 bottles", "reason_for_recall": "Cross Contamination w/Other Products: During stability testing chromatographic review revealed extraneous peaks identified as acetaminophen and codeine.", "recall_initiation_date": "20120807", "center_classification_date": "20121025", "termination_date": "20130327", "report_date": "20121031", "code_info": "Lot A 303M, Exp. June 2014"}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62511", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Distribution was nationwide, including Puerto Rico.  There was no foreign, military, or government distribution.", "recall_number": "D-075-2013", "product_description": "Levothroid (levothyroxine sodium tablets, USP), 50 mcg., 100-count bottles, Rx only, NDC 0456-1321-01,   Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.", "product_quantity": "13,692/100-tablet bottles", "reason_for_recall": "cGMP Deviations; does not meet in process specification requirements", "recall_initiation_date": "20120709", "center_classification_date": "20121203", "termination_date": "20131114", "report_date": "20121212", "code_info": "Lot #1097830 exp. 1/31/2013"}, {"status": "Terminated", "city": "Salt Lake City", "state": "UT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62384", "recalling_firm": "Actavis", "address_1": "575/577/579 Chipeta Way", "address_2": "N/A", "postal_code": "84108-1222", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1693-2012", "product_description": "Fentanyl Transdermal System, 100 mcg/h, each transdermal system contains: 10 mg fentanyl and 0.4 mL alcohol USP, Rx only, supplied in single pouches (NDC 0591-3214-54 (pouch)), 5 pouches per carton (NDC 0591-3214-72 (Carton)), Manufactured by Watson laboratories Inc., Corona, CA, Distributed by: Watson, Pharma Inc.", "product_quantity": "98,088 cartons (5 pouches per carton)", "reason_for_recall": "Subpotent; some patches may not contain fentanyl gel", "recall_initiation_date": "20120711", "center_classification_date": "20120925", "termination_date": "20130410", "report_date": "20121003", "code_info": "Lot number 455040A (carton) 455040 (pouch)", "more_code_info": ""}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63406", "recalling_firm": "Earthborn Products, Inc.", "address_1": "9275 Sky Park Ct Ste 101", "address_2": "N/A", "postal_code": "92123-4386", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-009-2013", "product_description": "Colloidal Silver, 100 ppm TDS, Natural Mineral Supplement, sold in a) 2 fl.oz (59.15 mL), b) 8 fl.oz (236.6 mL), c) 16 fl.oz (473.2 mL), d) 32 fl.oz (946.4 mL), e) 64 fl.oz (1.89 L), and f) 1 Gal. (3.78 L), Distributed by: Earthborn Products, San Diego, CA  92103.", "product_quantity": "161 gallons", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: This product is being recalled because FDA issued a final rule establishing that all over-the-counter (OTC) drug products containing colloidal silver ingredients or silver salts for internal or external use are not generally recognized as safe and effective and are misbranded.", "recall_initiation_date": "20121005", "center_classification_date": "20121018", "termination_date": "20130228", "report_date": "20121024", "code_info": "Lot #:  009-22-A011, 011-28-A011, 004-01-A012, 005-24-A012, 007-24-A012, and 008-08-A012."}, {"country": "United States", "city": "Westborough", "address_1": "201 Flanders Rd", "reason_for_recall": "GMP deficiencies", "address_2": "", "product_quantity": "", "code_info": "All lot codes within expiry", "center_classification_date": "20121114", "distribution_pattern": "Nationwide", "state": "MA", "product_description": "All Non-Sterile Products manufactured by Ameridose LLC, Westborough, MA.  A complete list of all products subject to this recall can be accessed on-line at www.ameridose.com", "report_date": "20121121", "classification": "Class II", "openfda": {}, "recalling_firm": "Ameridose LLC", "recall_number": "D-055-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "63585", "termination_date": "20160725", "more_code_info": "", "recall_initiation_date": "20121031", "postal_code": "01581-1032", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lincolnton", "state": "NC", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "62827", "recalling_firm": "Actavis Mid Atlantic LLC", "address_1": "1877 Kawai Rd", "address_2": "N/A", "postal_code": "28092-5905", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide & Puerto Rico", "recall_number": "D-005-2013", "product_description": "Prometh VC Plain, Each 5mL contains: Promethazine Hydrochloride 6.25mg & Phenylephrine Hydrochloride 5mg, One Pint Bottles (473mL), Rx Only, Manufactured by: Actavis Mid Atlantic, LLC., 1877 Kawaii Road, Lincolnton, NC, 28092, USA, NDC 0472-1628-16.", "product_quantity": "14,868 Bottles", "reason_for_recall": "Impurities/Degradation Products: Recalled lots do not meet room temperature stability specification for unknown degradant.", "recall_initiation_date": "20120814", "center_classification_date": "20121009", "termination_date": "20130627", "report_date": "20121017", "code_info": "X111001, X111008, X111030, Exp 10/13"}, {"status": "Terminated", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62900", "recalling_firm": "Carefusion 213, Llc", "address_1": "1550 Northwestern Dr", "address_2": "N/A", "postal_code": "79912-8000", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "IL, MO, and NJ", "recall_number": "D-004-2013", "product_description": "ChloraPrep One-Step (2% w/v chlorhexidine gluconate and 70% v/v isopropyl alcohol) Patient Preoperative Skin Preparation, 3mL Applicators, 25 Applicators per Carton, Single Use, Latex Free, Applicator is STERILE if package is intact, NDC 54365-400-01.", "product_quantity": "576 Cartons", "reason_for_recall": "Lack of Assurance of Sterility: Firm mistakenly released quarantined, non conforming material that failed sterility testing.", "recall_initiation_date": "20120423", "center_classification_date": "20121003", "termination_date": "20130911", "report_date": "20121010", "code_info": "Lot 52894, Product Code: 260400"}, {"status": "Terminated", "city": "Morrow", "state": "GA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "63395", "recalling_firm": "Abc Compounding Company Inc", "address_1": "6970 Jonesboro Rd", "address_2": "N/A", "postal_code": "30260", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-011-2013", "product_description": "Earth Force, Ltd., Power Towels, QS Plus Hand Sanitizing Wipes (antiseptic), 50 pre-moistened Wipes, Manufactured by: ABC Compounding Co., Inc., P.O. Box 16247, Atlanta, GA 30321.", "product_quantity": "66 rolls of wipes", "reason_for_recall": "Chemical Contamination: QS Plus wipes were found to be contaminated with different substance (7820, Graffiti Remover).", "recall_initiation_date": "20110210", "center_classification_date": "20121022", "termination_date": "20121030", "report_date": "20121031", "code_info": "Lot #3220"}, {"status": "Terminated", "city": "Concord", "state": "NC", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "63127", "recalling_firm": "McKesson Packaging Services", "address_1": "7101 Weddington Rd NW", "address_2": "N/A", "postal_code": "28027-3412", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-002-2013", "product_description": "buPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, UD 100 Tablets (10 x 10) per carton, Rx only, Mfg By: CMIC-VPS Corporation, Cranbury, New Jersey  08512; blister barcode N (01)003 63739 450 10 3, Dist By: McKesson Packaging, Concord, NC  28027; NDC 63739-450-10, carton barcode 6373945010.", "product_quantity": "674 cartons", "reason_for_recall": "Failed USP Dissolution Test Requirements: Possible out-of-specification dissolution results at the 8 hour stability testing point.", "recall_initiation_date": "20120329", "center_classification_date": "20121001", "termination_date": "20130411", "report_date": "20121010", "code_info": "Lot #: 0075375, 0074584, Exp 08/12"}, {"status": "Terminated", "city": "Sarasota", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63378", "recalling_firm": "DermaCare, Inc.", "address_1": "458 Island Circle", "address_2": "N/A", "postal_code": "34242", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-035-2013", "product_description": "UP & UP brand, kid's foaming hand sanitizer, alcohol free, 99.9% effective against germs, Sweet s'melon,  6.7FL oz (200mL), Distributed by Target Corp., Minneapollis, MN 55403", "product_quantity": "43,272 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Laboratory findings of high total plate count above specification.", "recall_initiation_date": "20120917", "center_classification_date": "20121101", "termination_date": "20140801", "report_date": "20121107", "code_info": "Batch 2082-01085, 1852-01085, 2082-01213, 2152-01261, and 1782-01084", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA018963"], "brand_name": ["CHOLETEC"], "generic_name": ["MEBROFENIN"], "manufacturer_name": ["Bracco Diagnostics Inc"], "product_ndc": ["0270-0083"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["MEBROFENIN"], "spl_id": ["065f7585-2b61-6a59-42ef-b5fabc62d8b0"], "spl_set_id": ["fd085485-998d-42a3-879a-b2d96cb8aed7"], "package_ndc": ["0270-0083-20"], "is_original_packager": [true], "unii": ["7PV0B6ED98"]}, "product_type": "Drugs", "event_id": "63535", "recalling_firm": "Bracco Diagnostic Inc", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-095-2013", "product_description": "Choletec - Kit for the Preparation of Technetium Tc 99m Mebrofenin, 10 vials per box, Nonradioactive, Diagnostic Use, For Intravenous Use, Multidose, Rx Only, Manufactured for Bracco Diagnostics Inc. Princeton, NJ  08543, by Hollister-Stier Laboratories LLC, Spokane Washington 99207, NDC 0270-0083-20.", "product_quantity": "196,280 Vials", "reason_for_recall": "Presence of Particulate Matter; potential for charcoal particulates", "recall_initiation_date": "20120814", "center_classification_date": "20121219", "termination_date": "20130906", "report_date": "20121226", "code_info": "Lot #s:  C0672, Exp 09/30/2012; C0689, Exp 10/31/2012; C0723, Exp 12/31/2012; C0799, Exp 02/28/2013; C0852, Exp 05/31/2013.", "more_code_info": ""}, {"status": "Terminated", "city": "Round Lake", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63189", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "Route 120 And Wilson Rd", "address_2": "N/A", "postal_code": "60073-9799", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1690-2012", "product_description": "Lactated Ringer's Injection USP, packaged in a) 250 mL AVIVA Container, product code 6E2322B, NDC 0338-6307-02; b) 500 mL AVIVA Container, product code 6E2323, NDC 0338-6307-03; Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA", "product_quantity": "55,664 containers", "reason_for_recall": "Chemical Contamination: The IV solutions were packaged in AVIVA containers which may contain trace levels of cumene hydroperoxide (CHP).", "recall_initiation_date": "20120921", "center_classification_date": "20120925", "termination_date": "20150504", "report_date": "20121003", "code_info": "Lot #: a) C847749, Exp 11/12; C847897, Exp 12/12; C860668, Exp 04/13; b) C855445, Exp 09/13; C861492, Exp 12/13", "more_code_info": ""}, {"status": "Terminated", "city": "Corona", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63509", "recalling_firm": "Watson Laboratories Inc", "address_1": "311 Bonnie Cir", "address_2": "N/A", "postal_code": "92880-2882", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-014-2013", "product_description": "Lutera (levonorgestrel and ethinyl estradiol) Tablets USP, 0.1 mg/0.02 mg, inert tablets, 28-count tablets per dispenser packaged in 6 Tablet Dispensers per carton, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA  92880 USA; Distributed by: Watson Pharma, Inc., Parsippany, NJ  07054 USA; NDC 52544-949-28.", "product_quantity": "67,860 cartons", "reason_for_recall": "Cross Contamination With Other Products: The firm recalled Zovia, Lutera, Necon, and Zenchent, because certain lots could potentially be contaminated with trace amounts of Hydrochlorothiazide (HCTZ).", "recall_initiation_date": "20121019", "center_classification_date": "20121024", "termination_date": "20131121", "report_date": "20121031", "code_info": "Lot #: 517921AA, 517921AB, 517922AA, 517922AB, 517923AA, 517923AB, Exp 03/31/14"}, {"status": "Terminated", "city": "Corona", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63509", "recalling_firm": "Watson Laboratories Inc", "address_1": "311 Bonnie Cir", "address_2": "N/A", "postal_code": "92880-2882", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-017-2013", "product_description": "Necon 1/35-28 (norethindrone and ethinyl estradiol) Tablets USP, 1 mg/35 mcg, inert tablets, 28-count tablets per dispenser packaged in 6 Tablet Dispensers per carton, Rx only, Manufactured by: Watson Pharma, Inc., A subsidiary of Watson Pharmaceuticals, Inc., Corona, CA  92880 USA; NDC 52544-552-28.", "product_quantity": "6,466 cartons", "reason_for_recall": "Cross Contamination With Other Products: The firm recalled Zovia, Lutera, Necon, and Zenchent, because certain lots could potentially be contaminated with trace amounts of Hydrochlorothiazide (HCTZ).", "recall_initiation_date": "20121019", "center_classification_date": "20121024", "termination_date": "20131121", "report_date": "20121031", "code_info": "Lot #: 514743AB, Exp 09/30/13"}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62511", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Distribution was nationwide, including Puerto Rico.  There was no foreign, military, or government distribution.", "recall_number": "D-080-2013", "product_description": "Thyro-Tab 0.125 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.", "product_quantity": "1,924,174 tablets", "reason_for_recall": "cGMP Deviations; does not meet in process specification requirements", "recall_initiation_date": "20120709", "center_classification_date": "20121203", "termination_date": "20131114", "report_date": "20121212", "code_info": "Lot #HB27811"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076477"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Sun Pharmaceutical Industries Inc."], "product_ndc": ["63304-827", "63304-828", "63304-829", "63304-830"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["259255", "617310", "617311", "617312"], "spl_id": ["24508d3d-eec0-4c5c-bfaa-d6e01a03fe80"], "spl_set_id": ["595ab888-6b55-4642-a32f-e8521821ed81"], "package_ndc": ["63304-827-90", "63304-827-05", "63304-828-90", "63304-828-05", "63304-829-90", "63304-829-05", "63304-830-90", "63304-830-05"], "is_original_packager": [true], "unii": ["48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "63759", "recalling_firm": "Ranbaxy Inc.", "address_1": "600 College Rd E Ste 2100", "address_2": "N/A", "postal_code": "08540-6636", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and PR", "recall_number": "D-072-2013", "product_description": "Atorvastatin Calcium Tablets, 40 mg, a) 90 tablets per bottle, b) 500 tablets per bottle, Rx only, Manufactured for: Ranbaxy Pharmaceuticals Inc., Jacksonville, FL 32257, USA, by: Ranbaxy Laboratories Ltd., New Delhi - 110019, India, NDC #: a)  63304-829-90, b) 63304-829-05.", "product_quantity": "157,026 Bottles", "reason_for_recall": "Presence of Particulate Matter: Certain batches of Atorvastatin tablets 10 mg, 20 mg and 40 mg may contain small glass particulates.", "recall_initiation_date": "20121109", "center_classification_date": "20121129", "termination_date": "20140428", "report_date": "20121205", "code_info": "a) 40 mg 90 count, Lot #s: 2434265, 2434266, 2434824, 2434826, 2434827, 2434828, 2434829, 2434830, 2434831, Exp 07/31/2014; 2436580, 2436725, 2436727, 2436729, 2437377, 2437380, 2437941, 2437943, 2437944, 2437949, 2437950, 2437955, Exp 08/31/2014.  b) 40 mg 500 count, Lot #s: 2437956, 2437957, 2440675, Exp 08/31/2014."}, {"country": "United States", "city": "Gainesville", "address_1": "2481 Hilton Dr", "reason_for_recall": "Labeling: Label Mix-up: Product was incorrectly labeled,\"Tabs\" instead of \"Capsules.\"", "address_2": "", "product_quantity": "5 bottles", "code_info": "Lot # A00984 Exp. 01/14", "center_classification_date": "20121109", "distribution_pattern": "GA and TN.", "state": "GA", "product_description": "Venlafaxine ER 150mg, 30 Tabs bottle, Generic for: Effexor, Packaged and Distributed by: Stat Rx USA, LLC, Gainesville, GA 30501 NDC 42549-684-30", "report_date": "20121121", "classification": "Class III", "openfda": {}, "recalling_firm": "Stat Rx USA", "recall_number": "D-051-2013", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "63659", "termination_date": "20130131", "more_code_info": "", "recall_initiation_date": "20120823", "postal_code": "30501-6213", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63384", "recalling_firm": "Raritan Pharmaceuticals, Inc.", "address_1": "8 Joanna Ct", "address_2": "N/A", "postal_code": "08816-2108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-032-2013", "product_description": "DRxChoice Fiber Capsules, 25 capsules per bottle, Psyllium Husk Fiber, Mfg. by Raritan Pharmaceuticals, East Brunswick, NJ, UPC 3-68163-11925-1.", "product_quantity": "17,136 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.", "recall_initiation_date": "20120904", "center_classification_date": "20121025", "termination_date": "20141007", "report_date": "20121031", "code_info": "Lots: 16274, Exp 06/15; 16471 Exp 08/15"}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "62911", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and PR", "recall_number": "D-1703-2012", "product_description": "Famotidine Tablets USP, 20 mg, 100 count bottles, Rx Only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. NDC 0378-3020-01", "product_quantity": "31,867 Bottles", "reason_for_recall": "Impurities/Degradation Products: Out of specification results for Related Compound during routine stability testing.", "recall_initiation_date": "20120628", "center_classification_date": "20120928", "termination_date": "20130329", "report_date": "20121010", "code_info": "Lot: 3018952, Exp 08/12"}, {"country": "United States", "city": "Framingham", "address_1": "697 Waverly St", "reason_for_recall": "GMP Deviations", "address_2": "", "product_quantity": "", "code_info": "All lot codes", "center_classification_date": "20121114", "distribution_pattern": "Nationwide  Japan", "state": "MA", "product_description": "All Non Sterile Products manufactured by NECC (New England Compounding Center), Framingham, MA.  A complete list of products can be found on their website at www.neccrx.com", "report_date": "20121121", "classification": "Class II", "openfda": {}, "recalling_firm": "New England Compounding Center", "recall_number": "D-053-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "63511", "termination_date": "20161007", "more_code_info": "", "recall_initiation_date": "20121006", "postal_code": "01702-8589", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63384", "recalling_firm": "Raritan Pharmaceuticals, Inc.", "address_1": "8 Joanna Ct", "address_2": "N/A", "postal_code": "08816-2108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-031-2013", "product_description": "Premier Value Fiber Plus Calcium Supplement Capsules, 120 capsules per bottle, Distributed by: Chain Drug Consortium, LLC, Boca Raton, FL, UPC 8-40986-01987-6", "product_quantity": "96 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.", "recall_initiation_date": "20120904", "center_classification_date": "20121025", "termination_date": "20141007", "report_date": "20121031", "code_info": "Lot 15087, Exp 08/15"}, {"status": "Terminated", "city": "Corona", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63509", "recalling_firm": "Watson Laboratories Inc", "address_1": "311 Bonnie Cir", "address_2": "N/A", "postal_code": "92880-2882", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-015-2013", "product_description": "Zenchent (norethindrone and ethinyl estradiol) Tablets USP, 0.4 mg/0.035 mg, 28-count tablets per dispenser packaged in 6 Tablet Dispensers per carton, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA  92880 USA; Distributed by: Watson Pharma, Inc., Corona, CA  92880 USA; NDC 52544-953-28.", "product_quantity": "12,333 cartons", "reason_for_recall": "Cross Contamination With Other Products: The firm recalled Zovia, Lutera, Necon, and Zenchent, because certain lots could potentially be contaminated with trace amounts of Hydrochlorothiazide (HCTZ).", "recall_initiation_date": "20121019", "center_classification_date": "20121024", "termination_date": "20131121", "report_date": "20121031", "code_info": "Lot #: 514767AA, Exp 03/31/14"}, {"status": "Terminated", "city": "Cranbury", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63031", "recalling_firm": "Caraco Pharmaceutical Laboratories Ltd.", "address_1": "270 Prospect Plains Rd", "address_2": "N/A", "postal_code": "08512-3605", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "One direct account - Caraco Pharmaceutical Labroatories, LTD  Detroit, Michigan  78 sub accounts", "recall_number": "D-003-2013", "product_description": "Nimodipine Capsules 30 mg, Rx Only, For Institutional Use Only, a) 30-count unit dose Capsules (5x6 blister cards per carton), NDC 57664-135-64, b) 100-count unit dose Capsules (25x4 blister cards per carton),  NDC 57664-135-65, Distributed by: Caraco Pharmaceutical Laboratories, Ltd. Detroit, MI 48202 Affiliate of Sun Pharmaceutical Industries, Inc.", "product_quantity": "a) 2424 Cartons b)  2675 Cartons", "reason_for_recall": "Crystallization: Presence of crystals of Nimodipine within the capsule solution.", "recall_initiation_date": "20120821", "center_classification_date": "20121003", "termination_date": "20131119", "report_date": "20121010", "code_info": "Lot: a) 3305.039B, Exp 07/13; b) 3305.039A, Exp 07/13"}, {"status": "Terminated", "city": "Detroit", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63628", "recalling_firm": "Caraco Pharmaceutical Laboratories, Ltd.", "address_1": "1150 Elijah McCoy Dr", "address_2": "N/A", "postal_code": "48202-3344", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-089-2013", "product_description": "traMADOL Hydrochloride Tablets, USP 50 mg, 1000-count tablets per bottle, Manufactured by: Sun Pharmaceuticals Industries, Dadra 396 191, India; Distributed by: Caraco Pharmaceutical Laboratories, Ltd., 1150 Elijah McCoy Drive, Detroit, MI  48202; NDC 57664-377-18.", "product_quantity": "2,264 bottles", "reason_for_recall": "Adulterated Presence of Foreign Tablets: A customer complaint was received that a bottle of Tramadol HCl Tablets USP 50 mg contained some tablets of Metoprolol Tartrate Tablets USP, 50 mg.", "recall_initiation_date": "20121105", "center_classification_date": "20121206", "termination_date": "20130712", "report_date": "20121212", "code_info": "Lot # GKK1373, Exp 09/13"}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63384", "recalling_firm": "Raritan Pharmaceuticals, Inc.", "address_1": "8 Joanna Ct", "address_2": "N/A", "postal_code": "08816-2108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-025-2013", "product_description": "Up&Up Psyllium Fiber Supplement, 100% natural psyllium husk, Fiber Therapy for Regularity/Fiber Supplement, 160 capsules per bottle,  Distributed by: Target Corp., Minneapolis, MN 55403, Made in USA,  NDC 11673-059-87, UPC 3-68163-11926-8.", "product_quantity": "48,120 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.", "recall_initiation_date": "20120904", "center_classification_date": "20121025", "termination_date": "20141007", "report_date": "20121031", "code_info": "Item 119160TGT; Lots15952, Exp 06/15; 16459, 16460, 16463, Exp 07/15; 16475, Exp 08/15"}, {"status": "Terminated", "city": "Lincolnton", "state": "NC", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "62827", "recalling_firm": "Actavis Mid Atlantic LLC", "address_1": "1877 Kawai Rd", "address_2": "N/A", "postal_code": "28092-5905", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide & Puerto Rico", "recall_number": "D-006-2013", "product_description": "Prometh VC with Codeine Cough Syrup, CV, Each 5mL contains: Codeine phosphate 10mg; promethazine hydrochloride 6.25mg; phenylephrine hydrochloride 5mg, One Pint Bottles (473mL), Rx Only, Manufactured by: Actavis Mid Atlantic LLC., 1877 Kawaii Road, Lincolnton, NC 28092 USA, NDC 0472-1629-16", "product_quantity": "19,980 Bottles", "reason_for_recall": "Impurities/Degradation Products: Recalled lots do not meet room temperature stability specification for unknown degradant.", "recall_initiation_date": "20120814", "center_classification_date": "20121009", "termination_date": "20130627", "report_date": "20121017", "code_info": "X110042, X110051, X110064, Exp 09/13"}, {"status": "Terminated", "city": "Zebulon", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63691", "recalling_firm": "GlaxoSmithKline, LLC.", "address_1": "1011 North Arendell Ave", "address_2": "N/A", "postal_code": "27597-1217", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-068-2013", "product_description": "Arranon (nelarabine) Injection 5mg/mL, 50mL Vials, Rx only,  For I.V. Infusion only, GlaxoSmith Kline, Research Triangle Park, NC 27709. Made in England, NDC 0007-4401-06", "product_quantity": "1,319 vials", "reason_for_recall": "Impurities/Degradation Products: Potential for drug related impurities to exceed the specification limits.", "recall_initiation_date": "20121008", "center_classification_date": "20121127", "termination_date": "20140911", "report_date": "20121205", "code_info": "Lot # C536707 Exp 02/14, C538830 Exp.02/14,  C533169 Exp. 02/14"}, {"status": "Terminated", "city": "Key Colony Beach", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "62543", "recalling_firm": "Coral Rock Man, Inc.", "address_1": "420 11th Street", "address_2": "N/A", "postal_code": "33051", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Product was distributed to three distributors/wholesalers and then distributed nationwide by internet and retail sales.", "recall_number": "D-038-2013", "product_description": "X-ROCK 3 Day Pill For Men, supplied in 1 and 2 capsule blister packs and 6, 12 and 24 count bottles, UPC 0 00309 50792 7, Distributed by:  MATE Enterprises, Miami, Florida 33139, Some labeled as: Manufactured by CRM Laboratories, Distributed by XRock Industries, Ft. Lauderdale, FL,  Also, labeled as X-Rock 3 Day Pill For Erectile Refunction, Distributed by www. CoralXRock.Com, Florida Keys, Florida", "product_quantity": "unknown", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Products tested positive for Sildenafil and analogs of Sildenafil.", "recall_initiation_date": "20120716", "center_classification_date": "20121101", "termination_date": "20151130", "report_date": "20121107", "code_info": "All Lots All codes.", "more_code_info": ""}, {"status": "Terminated", "city": "Broomfield", "state": "CO", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA078692"], "brand_name": ["CETIRIZINE HYDROCHLORIDE"], "generic_name": ["CETIRIZINE HYDROCHLORIDE"], "manufacturer_name": ["Sandoz Inc"], "product_ndc": ["0781-5283"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["CETIRIZINE HYDROCHLORIDE"], "rxcui": ["1014643"], "spl_id": ["973d0d70-f69f-44b6-98f0-f436e63bd15a"], "spl_set_id": ["817d07cf-5e31-421f-9e95-943bae01f5b0"], "package_ndc": ["0781-5283-06", "0781-5283-64", "0904-5878-33"], "is_original_packager": [true], "upc": ["0307815283643"], "unii": ["64O047KTOA"]}, "product_type": "Drugs", "event_id": "63224", "recalling_firm": "Sandoz Incorporated", "address_1": "2555 W Midway Blvd", "address_2": "N/A", "postal_code": "80020-1632", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-008-2013", "product_description": "Children's Cetirizine HCl Chewable Tablets 5 mg, 30 count blister pack, Manufactured in India by Sandoz Private Ltd., for Sandoz Inc., Princeton, NJ NDC 0781-5283-64 --- ALSO sold under  Major brand All Day Allergy Children's Cetirizine HCl 5 mg, 5 count blister pack, Major Pharmaceuticals, Livonia, MI NDC 0904-5878-33", "product_quantity": "67,937 x 30 tablet cartons; 24,640 x 5 tablet cartons", "reason_for_recall": "Impurity/Degradation; exceeded impurity specification at the 8 and 15 month time points (betacyclodextrin ester 1&amp;2)", "recall_initiation_date": "20120920", "center_classification_date": "20121018", "termination_date": "20130114", "report_date": "20121024", "code_info": "NDC 0781-5283-64 lots: BT2862, BT7986, BT7994, BW0652, CC1961, and CA3437; NDC 0904-5878-33 lot BW0665."}, {"status": "Terminated", "city": "Prince George", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63550", "recalling_firm": "American Enterprises LLC dba Sterling Gelatin", "address_1": "4595 Sandesara Dr", "address_2": "N/A", "postal_code": "23875-3045", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NJ", "recall_number": "D-062-2013", "product_description": "Limed Bone Gelatin, packaged in six 125 kg fiber drums and labeled in part PO NO.: P8095 GELATIN 75 BLOOM ITEM NO. RM 164.  MADE IN INDIA", "product_quantity": "750 kgs", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.", "recall_initiation_date": "20120921", "center_classification_date": "20121121", "termination_date": "20121128", "report_date": "20121128", "code_info": "Batch No. SG4704, Exp 02/22/2017."}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA200403"], "brand_name": ["HYDROMORPHONE HYDROCHLORIDE"], "generic_name": ["HYDROMORPHONE HYDROCHLORIDE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-1283", "0409-2552", "0409-3356", "0409-2540", "0409-3365", "0409-1312", "0409-1304"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["HYDROMORPHONE HYDROCHLORIDE"], "rxcui": ["897653", "897753", "897756", "897757", "897758", "1433251", "1724276", "1724383", "1724644"], "spl_id": ["58ff0e68-b78f-4ebd-a91b-b53bbdefc544"], "spl_set_id": ["e9c9ef18-7dfc-4322-b2fc-29b934c30f8b"], "package_ndc": ["0409-2552-11", "0409-2552-01", "0409-3356-11", "0409-3356-01", "0409-2540-11", "0409-2540-01", "0409-3365-11", "0409-3365-01", "0409-3365-10", "0409-1283-03", "0409-1283-31", "0409-1283-09", "0409-1283-10", "0409-1283-04", "0409-1283-05", "0409-1312-03", "0409-1312-30", "0409-1312-09", "0409-1312-10", "0409-1304-03", "0409-1304-31"], "is_original_packager": [true], "unii": ["L960UP2KRW"]}, "product_type": "Drugs", "event_id": "62854", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-020-2013", "product_description": "HYDROmorphone HCl Injection, USP, 2 mg/mL, 1 mL fill in a 2.5 mL Carpuject prefilled cartridge unit, packaged in 10-count Carpujects per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1312-30, Barcode (01) 1 030409 131230 9 (carton), (01) 0 030409 131230 2 (cartridge unit).", "product_quantity": "216,880 cartridge units", "reason_for_recall": "Superpotent (Single Ingredient) Drug: The prefilled cartridge unit has been found to be overfilled and contain more than the 1 mL labeled fill volume.", "recall_initiation_date": "20120815", "center_classification_date": "20121024", "termination_date": "20150529", "report_date": "20121031", "code_info": "Lot 12720LL, Exp 12/01/13"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA070914"], "brand_name": ["NALBUPHINE HYDROCHLORIDE"], "generic_name": ["NALBUPHINE HYDROCHLORIDE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-1463", "0409-1465", "0409-1464", "0409-1467"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["NALBUPHINE HYDROCHLORIDE"], "rxcui": ["904415", "904440", "1866543", "1866551"], "spl_id": ["ecc89b62-3c75-4fe9-bb5d-d65151ee3544"], "spl_set_id": ["6025e8d4-5083-4c3a-58a0-050e7b0b6150"], "package_ndc": ["0409-1463-71", "0409-1463-01", "0409-1465-71", "0409-1465-01", "0409-1464-61", "0409-1464-01", "0409-1467-61", "0409-1467-01"], "is_original_packager": [true], "unii": ["ZU4275277R"]}, "product_type": "Drugs", "event_id": "63884", "recalling_firm": "Hospira, Inc.", "address_1": "600 N Field Dr Bldg J45", "address_2": "", "postal_code": "60045", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico.", "recall_number": "D-096-2013", "product_description": "Nalbuphine HCl Injection, 20 mg/mL, 10 mL Multiple-dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1467-01", "product_quantity": "145,400 vials", "reason_for_recall": "Lack of Assurance of Sterility: Complains of a loose crimp applied to the fliptop vial; and a missing stopper and flip cap were received and therefore sterility cannot be assured.", "recall_initiation_date": "20121121", "center_classification_date": "20121220", "termination_date": "20140603", "report_date": "20121226", "code_info": "Lot #: 11-293-DK, Exp 05/01/13", "more_code_info": ""}, {"status": "Terminated", "city": "Pompano Beach", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "61669", "recalling_firm": "XRock Industries, LLC", "address_1": "571 Se 14th St", "address_2": "N/A", "postal_code": "33060-9315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Products were distributed nationwide and internationally to Australia, Bahamas, Bermuda, Canada, Croatia, Curacao, New Zealand, Trinidad and Tobago, U.S. Virgin Islands, Jamaica, and United Kingdom.", "recall_number": "D-037-2013", "product_description": "X-ROCK  For Men, Dietary Supplement, Manufactured by CRM Laboratories, Distributed by XRock Industries, PO Box 120863, Ft. Lauderdale, FL 33312,   0 00309 50792 7.                             UPC on labeling is:  0 00309 50792 7.    UPC in Press Release is:  0030950792.", "product_quantity": "215,000 capsules", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: product tested positive for PDE-5 Sildenafil and PDE-5 Hydroxythiohomosildenafil.  Hydroxythiohomosildenafil is an analog of sildenafil, an FDA approved prescription drug for Erectile Dysfunction (ED).", "recall_initiation_date": "20120421", "center_classification_date": "20121101", "termination_date": "20151130", "report_date": "20121107", "code_info": "UPC 0 00309 50792 7 All Lots", "more_code_info": ""}, {"status": "Terminated", "city": "Round Lake", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63189", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "Route 120 And Wilson Rd", "address_2": "N/A", "postal_code": "60073-9799", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1686-2012", "product_description": "5% Dextrose Injection USP, packaged in a) 250 mL AVIVA Container, product code 6E0062, NDC 0338-6346-02; b) 500 mL AVIVA Container, product code 6E0063, NDC 0338-6346-03; Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA", "product_quantity": "753,941 containers", "reason_for_recall": "Chemical Contamination: The IV solutions were packaged in AVIVA containers which may contain trace levels of cumene hydroperoxide (CHP).", "recall_initiation_date": "20120921", "center_classification_date": "20120925", "termination_date": "20150504", "report_date": "20121003", "code_info": "Lot #: a) C841114, C841254, Exp 09/12; C842229, C842898, C843037, C843326, C844209, Exp 10/12; C844456, C844928, C846089, C846246, C847178, Exp 11/12; C848044, C848804, C849869, C849810, C850313, Exp 12/12; C852574, C852673, C853168, C853275, C853473, Exp 01/13; C854331, C855098, C855551, Exp 02/13; C856690, C856815, C857813, Exp 03/13; C858829, C858951, C859884, C860049, C860304, C860304A, C860452, C861138, Exp 04/13; C861252, C861971, C862748, C862854, Exp 05/13; C865576, C865683, C866079, Exp 06/13; C866947, C867283, C867424, C867960, C868455, Exp 07/13; b) C818039, Exp 09/12; C821793, Exp 10/12; C824276, C825679, Exp 11/12; C828350, Exp 12/12; C830323, C832105, Exp 01/13; C834986, C836114, Exp 03/13; C840736, Exp 04/13; C843433, Exp 05/13; C844829, C845784, Exp 06/13; C848333, C850446, C850446A, Exp 07/13; C852376, C852939, Exp 08/13; C856443, C857417, C857656, C858381, Exp 10/13; C858498, C859470, C859652, Exp 11/13; C863365, Exp 12/13; C863738, C863852, C865451, C866392, Exp 01/14; C867846, Exp 02/14", "more_code_info": ""}]